Archive for the ‘Genetic Testing’ Category
The benefits and the costs of home DNA tests – Health and Happiness – Castanet.net
Photo: Contributed
Is the wealth of information about your individual health risks worth the anxiety of knowing?
DNA testing kits have made it possible to access previously unmined information about your health. As a huge advocate of preventative medicine, Ive explored the pros and cons of accessing this wealth of information to see whether your spit is worth the price tag and the consequences.
Firstly, what is it? Companies like 23andMe offer a home-based saliva collection kit you spit in the tube and send it to the lab. From there, your DNA is extracted from the spit and a process called genotyping analyses the DNA.
You then receive a report with your health predispositions (diseases you are more likely to get due to your genes) and your carrier status of certain diseases, such as cystic fibrosis.
The most obvious benefit of getting your DNA tested is identifying your personal health predispositions. For instance, the report might indicate youre at risk of getting type 2 diabetes, or heart disease. With this information, you can make changes to your lifestyle to help prevent these diseases from occurring, such as quitting smoking, drinking less caffeine or eating less sugar.
Despite these benefits, it is important to consider the emotional stress of receiving unfortunate results. Finding out you are at high risk of Alzheimers has a huge emotional impact on an individual and their family, especially as there is little you can do to prevent it.
Personally, I wouldnt want to know Im at high risk for a disease I cant do anything about I think the anxiety the knowledge would cause wouldnt be worth the information.
Its also important to note that genealogy results arent definitive. For instance, they may identify the gene that can cause high cholesterol, which in turn can increase the risk of heart disease. However, the test doesnt take into account any other personal or environmental factors, such as your diet, exercise and lifestyle. Without input from your own family doctor or a genetic counsellor, the results cannot be taken as gospel.
The uses of genealogy DNA databases extend beyond personal use for health and ancestry information, and this is the part where I begin to question the safety of using these kits. Although companies have rigorous privacy policies, they do still keep your DNA and information in a database in order to identify future clients that may be within your family tree.
This data is vulnerable to hackers, but also to police and immigration officials. The CBSA uses genealogy DNA testing in an immigration setting to ascertain a persons identity, such as the country they originate from.
From the uses we know about, to those yet to be found Im not sure I want my DNA in a database with unknown potential.
There are also important financial implications that accompany genetic testing, such as the fact that some insurance companies now say you must disclose any genetic risk information you are aware of, which can mean higher premiums for health, life and travel insurance.
Having mused over the idea for several weeks, with my mouse hovering over the Add to Cart button more than once, Ive decided genetic testing is not for me, for now. I personally dont think you should need a genetic test to tell you to live a healthier lifestyle to exercise more, eat more greens and get better sleep.
If its something youre thinking about, or have done, I would love to hear your thoughts on it. If not, take it from me get out for a cycle or a run, spend more time with your family and eat some broccoli with a smile on your face.
More here:
The benefits and the costs of home DNA tests - Health and Happiness - Castanet.net
Myriad Genetics Appoints Daniel K. Spiegelman to the Board of Directors and Announces Upcoming Retirement of John T. Henderson, M.D. – GlobeNewswire
SALT LAKE CITY, May 28, 2020 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics and precision medicine, today announced the election of Daniel K. Spiegelman, age 61, to its Board of Directors, effective immediately, expanding the Board to nine members. Additionally, Mr. Spiegelman was appointed to the audit committee of Myriads Board.
Mr. Spiegelman has served as a Chief Financial Officer in several diversified biotechnology companies spanning 30 years. He was most recently Executive Vice President and Chief Financial Officer of BioMarin Pharmaceuticals, Inc., a pharmaceutical company focused on development of first-in-class and best-in-class therapeutics for rare genetic diseases. Having retired from that position after eight years, Dan now serves on the board of Tizona Therapeutics, Inc., a private pharmaceutical company, and has previously served on a number of public and private biotech company boards.
We are excited to welcome Dan to the Myriad Board, said Louise Phanstiel, Chair of the Board of Myriad. Dan brings a deep understanding of the biotech industry along with strong finance, M&A and business development experience. His background of creating value and growing early stage as well as established companies will provide useful strategic insights in executing our global strategy for molecular diagnostics and precision medicine.
The Company also announced today that Director John T. Henderson, M.D. will retire from the board at the Companys Annual Meeting in December 2020. Dr. Henderson joined the Board of Myriad in 2004 and has served as Chair of the Board from April 2005 through March 2020.
It has been a privilege to play a part of Myriads journey in becoming a leader in providing trusted healthcare advice to patients and their physicians, said Henderson. I have treasured the opportunity to work with so many Myriad employees whose passion and dedication to pioneering best of class precision medicine is unsurpassed. I certainly look forward to the companys continued growth and success.
In commenting on Dr. Hendersons pending retirement, Louise Phanstiel said, The Board sincerely appreciates all of Johns many contributions to Myriad as a leader, a colleague and friend. John has led with integrity and caring about Myriads Vision and Mission. He will be deeply missed and we wish him all the best.
About Myriad Genetics
Myriad Genetics Inc., is a leading personalized medicine company dedicated to being a trusted advisor transforming patient lives worldwide with pioneering molecular diagnostics. Myriad discovers and commercializes molecular diagnostic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs. Myriad is focused on three strategic imperatives: transitioning and expanding its hereditary cancer testing markets, diversifying its product portfolio through the introduction of new products and increasing the revenue contribution from international markets. For more information on how Myriad is making a difference, please visit the Company's website: http://www.myriad.com.
Myriad, the Myriad logo, BART, BRACAnalysis, Colaris, Colaris AP, myPath, myRisk, Myriad myRisk, myRisk Hereditary Cancer, myChoice, myPlan, BRACAnalysis CDx, Tumor BRACAnalysis CDx, myChoice HRD, Vectra, Prequel, ForeSight, GeneSight and Prolaris are trademarks or registered trademarks of Myriad Genetics, Inc. or its wholly owned subsidiaries in the United States and foreign countries. MYGN-F, MYGN-G.
Lynparza is a registered trademark of AstraZeneca.
Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to Mr. Spiegelman providing useful strategic insights in executing the Companys global strategy for molecular diagnostics and precision medicine; Dr. Henderson retiring from the board at the Companys Annual Meeting in December 2020; and the Companys strategic directives under the caption "About Myriad Genetics." These "forward-looking statements" are based on management's current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by forward-looking statements. These risks and uncertainties include, but are not limited to: uncertainties associated with COVID-19, including its possible effects on our operations and the demand for our products and services; our ability to efficiently and flexibly manage our business amid uncertainties related to COVID-19; the risk that sales and profit margins of our molecular diagnostic tests and pharmaceutical and clinical services may decline; risks related to our ability to transition from our existing product portfolio to our new tests, including unexpected costs and delays; risks related to decisions or changes in governmental or private insurers reimbursement levels for our tests or our ability to obtain reimbursement for our new tests at comparable levels to our existing tests; risks related to increased competition and the development of new competing tests and services; the risk that we may be unable to develop or achieve commercial success for additional molecular diagnostic tests and pharmaceutical and clinical services in a timely manner, or at all; the risk that we may not successfully develop new markets for our molecular diagnostic tests and pharmaceutical and clinical services, including our ability to successfully generate revenue outside the United States; the risk that licenses to the technology underlying our molecular diagnostic tests and pharmaceutical and clinical services and any future tests and services are terminated or cannot be maintained on satisfactory terms; risks related to delays or other problems with operating our laboratory testing facilities and our healthcare clinic; risks related to public concern over genetic testing in general or our tests in particular; risks related to regulatory requirements or enforcement in the United States and foreign countries and changes in the structure of the healthcare system or healthcare payment systems; risks related to our ability to obtain new corporate collaborations or licenses and acquire new technologies or businesses on satisfactory terms, if at all; risks related to our ability to successfully integrate and derive benefits from any technologies or businesses that we license or acquire; risks related to our projections about our business, results of operations and financial condition; risks related to the potential market opportunity for our products and services; the risk that we or our licensors may be unable to protect or that third parties will infringe the proprietary technologies underlying our tests; the risk of patent-infringement claims or challenges to the validity of our patents or other intellectual property; risks related to changes in intellectual property laws covering our molecular diagnostic tests and pharmaceutical and clinical services and patents or enforcement in the United States and foreign countries, such as the Supreme Court decisions in Mayo Collab. Servs. v. Prometheus Labs., Inc., 566 U.S. 66 (2012), Assn for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576 (2013), and Alice Corp. v. CLS Bank Intl, 573 U.S. 208 (2014); risks of new, changing and competitive technologies and regulations in the United States and internationally; the risk that we may be unable to comply with financial operating covenants under our credit or lending agreements; the risk that we will be unable to pay, when due, amounts due under our credit or lending agreements; and other factors discussed under the heading "Risk Factors" contained in Item 1A of our most recent Annual Report on Form 10-K for the fiscal year ended June 30, 2019, which has been filed with the Securities and Exchange Commission, as well as any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10-Q or Current Reports on Form 8-K. All information in this press release is as of the date of the release, and Myriad undertakes no duty to update this information unless required by law.
Read the original:
Myriad Genetics Appoints Daniel K. Spiegelman to the Board of Directors and Announces Upcoming Retirement of John T. Henderson, M.D. - GlobeNewswire
Global Predictive Genetic Testing Market 2020: Type & Application, Innovation, Technology, Top Key Players, Regions & Forecast till 2025 -…
Global Predictive Genetic Testing market analysis forecast to 2025 is a specialized and in-depth study of the industry with a focus on the global market trend. The report aims to provide an overview of global Predictive Genetic Testing market with detailed market segmentation by solution, deployment type, application, vertical and geography. The global Predictive Genetic Testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
Adroit Market Research provides analysis and insights regarding on Predictive Genetic Testing market the various factors expected to be prevalent throughout the forecasted period while providing their impacts on the markets growth.
Adroit Market Research provides analysis and insights regarding on Predictive Genetic Testing market the various factors expected to be prevalent throughout the forecasted period while providing their impacts on the markets growth.
Top Leading Key Players are:
Agilent, Technologies, Inc., BGI Genomics, F.Hoffman-La Roche Ltd., Genes In Life., Invitae Corporation, Illumina, Inc., 23andMe, Myriad Genetics, Inc., Pathway Genomics and Thermo Fisher Scientific, Inc.
Get sample copy of Predictive Genetic Testing Market report @ https://www.adroitmarketresearch.com/contacts/request-sample/1276
The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact is covered in the report. The Predictive Genetic Testing market report puts together a concise analysis of the growth factors influencing the current business scenario across various regions. Significant information pertaining to the industry analysis size, share, application, and statistics are summed in the report in order to present an ensemble prediction. Additionally, this report encompasses an accurate competitive analysis of major market players and their strategies during the projection timeline.
In addition, the report categorizes Predictive Genetic Testing market according to type, application, related technology, end user, etc. to provide the data explored. It also includes comprehensive data related to specific financial and business terms, projected market growth, market strategy, etc. This market report offers some presentations and illustrations about the market that comprises pie charts, graphs, and charts which presents the percentage of the various strategies implemented by the service providers in the Global Predictive Genetic Testing Market.
Read complete report with TOC at: https://www.adroitmarketresearch.com/industry-reports/predictive-genetic-testing-market
The research report on global Predictive Genetic Testing market ensures users to remain competitive in the market. Also report helps to identify the new innovations and developments by existing key players to increase the growth of the global Predictive Genetic Testing market. This market study report covers all the geographical regions where competitive landscape exists by the players such as North America, Europe, Latin America, Asia-Pacific and Middle East Africa. Thus report helps to identify the key growth countries and regions.
Key Highlights Questions of Predictive Genetic Testing Market:What will be the size of the global Predictive Genetic Testing market in 2025?Which product is expected to show the highest market growth?Which application is projected to gain a lions share of the global Predictive Genetic Testing market?Which region is foretold to create the most number of opportunities in the global Predictive Genetic Testing market?Will there be any changes in market competition during the forecast period?Which are the top players currently operating in the global Predictive Genetic Testing market?
Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/1276
About Us :
Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a markets size, key trends, participants and future outlook of an industry. We intend to become our clients knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.
Contact Us :
Ryan JohnsonAccount Manager Global3131 McKinney Ave Ste 600, Dallas,TX 75204, U.S.APhone No.: USA: +1 972-362 -8199 / +91 9665341414
See the article here:
Global Predictive Genetic Testing Market 2020: Type & Application, Innovation, Technology, Top Key Players, Regions & Forecast till 2025 -...
Impact of COVID-19 Outbreak on Newborn and Prenatal Genetic Testing Market Analysis 2019 Growth by Top Companies and Trends by Types, Treatment,…
The report on the Newborn and Prenatal Genetic Testing market provides a birds eye view of the current proceeding within the Newborn and Prenatal Genetic Testing market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Newborn and Prenatal Genetic Testing market and offers a clear assessment of the projected market fluctuations during the forecast period. The different factors that are likely to impact the overall dynamics of the Newborn and Prenatal Genetic Testing market over the forecast period (2019-2029) including the current trends, growth opportunities, restraining factors, and more are discussed in detail in the market study.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2019 to 2025.
The Newborn and Prenatal Genetic Testing market report firstly introduced the basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the worlds main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the Newborn and Prenatal Genetic Testing market report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.
Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2657649&source=atm
The major players profiled in this Newborn and Prenatal Genetic Testing market report include:
The key players covered in this studyPerkin ElmerVerinata HealthSequenom, Inc.Agilent Technologies, Inc.Bio-Rad Laboratories, Inc.Natera, Inc.Illumina, Inc.Ariosa DiagnosticsBGICapitalBio MedLab
Market segment by Type, the product can be split intoPCRFISHaCGHNIPTMSSMarket segment by Application, split intoHospitalClinicOthers
Market segment by Regions/Countries, this report coversNorth AmericaEuropeChinaJapanSoutheast AsiaIndiaCentral & South America
The study objectives of this report are:To analyze global Newborn and Prenatal Genetic Testing status, future forecast, growth opportunity, key market and key players.To present the Newborn and Prenatal Genetic Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.To strategically profile the key players and comprehensively analyze their development plan and strategies.To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Newborn and Prenatal Genetic Testing are as follows:History Year: 2015-2019Base Year: 2019Estimated Year: 2020Forecast Year 2020 to 2026For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2657649&licType=S&source=atm
Key Market Related Questions Addressed in the Report:
Important Information that can be extracted from the Report:
Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2657649&source=atm
Continue reading here:
Impact of COVID-19 Outbreak on Newborn and Prenatal Genetic Testing Market Analysis 2019 Growth by Top Companies and Trends by Types, Treatment,...
84 Positive COVID-19 Cases Linked to Vancouver Fruit Processor – OPB News
UPDATE: (2:53 p.m. PT) Health officials in Clark County announced Tuesday that 84 people have tested positive for COVID-19 as part of an outbreak at a Vancouver fruit processor, Firestone Pacific Foods.
Sixty-nine employees have tested positive for COVID-19, four of whom arent Clark County residents. Another 15 people identified as close contacts of those cases have also testedpositive.
A total of 165 employees and 83 close contacts have been tested, with additional testing of employees and close contactsexpected.
The outbreak prompted Washington to pause Clark Countys request to move to Washingtons Phase 2 of reopening. It may be the largest non-health care-linked cluster of coronavirus cases in the greater Portland metroarea.
In total, 510 people have tested positive in Clark County and 25 people havedied.
The most recent available data from the Washington Department of Health show 19,265 confirmed coronavirus cases in the state and 1,050 knowndeaths.
The Oregon Health Authority reported 18 new coronavirus cases and one presumptive case in the state Tuesday. The states total number of known positive and presumptive cases is3,967.
Presumptive cases are people who have not tested positive but have COVID-19 symptoms and have had close contact with someone confirmed to be infected with thevirus.
Officials have reported no new coronavirus-related deaths for the second day in arow.
In Oregon, 148 people are known to have died fromCOVID-19.
Due to data reconciliation, one case originally reported as presumptive in Josephine County was determined to not be a case. Two other cases one in the 30-39 age group and one in the 70-79 age group were also determined not to becases.
Researchers at Oregon State University will look into Bends sewer system for genetic evidence of COVID-19 in an effort to help determine the virus prevalence in thecity.
Bend public works staff will collect sewage samples the weekend of May 30-31 as part of its Coronavirus Sewer Surveillance, the same weekend field workers from OSUs TRACE-COVID-19 project will gather nasal swab samples door-to-door inBend.
Sewer analysis results will be compared with nasal swab results to better detect the virus among symptomatic and asymptomatic carriers ofCOVID-19.
A really important step is to continue to validate the reliability of our sewer surveillance data with more traditional prevalence data from the medical community andresearchers.
Fortunately, the early indications suggest that sewer analysis is a reliable method, said Tyler Radniecki, an associate professor of environmental engineering said in astatement.
OSU said it has the lab capability to do genetic testing with a predicted turnaround time of about aweek.
The university said additional sewer surveillance projects are underway in WashingtonCounty.
In a three-sentence response to the Oregon Supreme Court, the Baker County Circuit Court Judge who vacated more than 20 of Gov. Kate Browns executive orders surrounding the states response to the coronavirus pandemic, told the court on Tuesday he wouldnt back down fromhisdecision.
I have elected to stand by my original ruling, Circuit Court Judge Matthew Shirtcliff wrote. I will not be vacating the May 18, 2020 Order Granting Preliminary Injunctive Relief and Denying Motions To Dismiss or takingotheraction.
A group of churches and eastern Oregon public officials have sued, arguing Browns executive orders exceed her authority understatelaw.
As Oregon counties continue to move forward with reopening, Portland International Airport has seen a small increase in travelers over the last twoweeks.
As states (and even other countries) begin to reopen, we expect the trends to continue slowly upward for air travel, said communications manager Susie Rantz with the Port ofPortland.
However, the virus is really in charge when it comes to air travel so its so hard to know what a few months from now might looklike.
Rantz said that passenger volumes at PDX are still down approximately 92% compared to this time last year. That decrease reached a bottom of nearly 96% inmid-April.
Airlines typically release their flight schedules on a quarterly basis, which saw dramatic reductions between April and June. Rantz said that passenger trends will become clearer when airlines update their Julyschedules.
The Oregon Employment Department announced Project Focus 100 on Tuesday, outlining a plan to address the 38,000 backlogged unemployment claims in the state.The department said it will continue to hire and train new employees, as well as assign experienced professionals on the oldest and most complexcases.
From May 29 to June 12, the agency said it will increase its outbound calls to resolve claims for people who have been waiting thelongest.
The Employment Department said it is trying out new ways of contacting people to let them know where their claims are in the system and said theyve identified ways to move claims out of processing traps that can delaythem.
See the article here:
84 Positive COVID-19 Cases Linked to Vancouver Fruit Processor - OPB News
Impact of Covid-19 Global Point-of-Care Genetic Testing Market (2020 To 2027) | Abbott (US), Roche (Switzerland), Thermo Fisher Scientific (US),…
Global Point-of-Care Genetic Testing Market research report delivers the analysis of the market outlook, framework, and socio-economic impacts. This report tries to covers the authenticate information of the market size, share, product footprint, revenue, and progress rate. All this information driven by primary and secondary researches, with reliable and authentic projections regarding the technical jargon. This study assesses the current landscape of the ever-evolving business sector and the present and future effects of COVID-19 on the market.
According to the current market situation, this report continuously observing promising growth of the global Point-of-Care Genetic Testing market. The report further suggests market appears to progress at an accelerating rate over the forecast period. Also, the major players are elaborated on the basis of the proprietary technologies, distribution channels, industrial penetration, manufacturing processes, and revenue. In addition, report also examines R&D developments, legal policies, and strategies of Point-of-Care Genetic Testing market players.
Leading companies reviewed in the Point-of-Care Genetic Testing Market report are:Abbott (US)Roche (Switzerland)Thermo Fisher Scientific (US)Cepheid (US)IQuum (US)Biocartis (Switzerland)Idaho Technologies (US)Optigene (UK)Lumora (UK)
Get Free Sample PDF (including full TOC, Tables and Figures) of Point-of-Care Genetic Testing Market @ https://www.glamresearch.com/report/global-point-of-care-genetic-testing-market-by-323536/#sample
Global Point-of-Care Genetic Testing Market Split by Product Type and Applications:On the basis of Types:
POCT Cancer KitsMolecular POC KitsPOCT In Antibiotic TherapiesAssay CartridgeOther
On the basis of Application:
Diagnostic LabsBio-Pharmaceutical IndustryAcademic InstitutionsOther
The latest research on the Point-of-Care Genetic Testing Market fundamentally delivers insights that can empower stakeholders, business owners, and field marketing executives to make effective investment decisions driven by facts and extremely thorough research. The study aims to provide an evaluation and deliver essential information on the competitive landscape to meet the unique requirements of the companies and individuals operating in the Point-of-Care Genetic Testing Market for the forecast period, 20202027. To help firms comprehend the Point-of-Care Genetic Testing industry in multiple ways, the report exhaustively assesses the share, size, and growth rate of the business worldwide.
Market, By regions:
Place Inquiry for Buying or Customization of Report: https://www.glamresearch.com/report/global-point-of-care-genetic-testing-market-by-323536/#inquiry
Report Highlights:
What Point-of-Care Genetic Testing Market Research Report Offers?
Chapters Define in TOC (Table of Content) of the Report:
Chapter 1: Market Survey, Drivers, Restraints and Good fortune, Segmentation overviewChapter 2: Market competitiveness by ManufacturersChapter 3: Production by RegionsChapter 4: Consumption by RegionsChapter 5: Production, By Types, Revenue and Market share by TypesChapter 6: Consumption, By Applications, Market share (%) and Growth Rate by ApplicationsChapter 7: Overall profiling and analysis of ManufacturersChapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expensesChapter 9: Supply Chain, Sourcing Strategy and Downstream BuyersChapter 10: Marketing Strategy Analysis, Distributors/TradersChapter 11: Market Influence Factors AnalysisChapter 12: Market PredictChapter 13: Point-of-Care Genetic Testing Research Findings and Conclusion, Appendix, methodology and data source
Access Full Report, here: https://www.glamresearch.com/report/global-point-of-care-genetic-testing-market-by-323536/
Read the original here:
Impact of Covid-19 Global Point-of-Care Genetic Testing Market (2020 To 2027) | Abbott (US), Roche (Switzerland), Thermo Fisher Scientific (US),...
Genetic Testing Industry 2020 Market Detailed by Size, Share, Growth, Revenue, Companies Analysis and Forecast Research Report 2026 – Cole of Duty
The Global Genetic Testing Market 2020 industry Research Report will provide a valuable insight with an emphasis on global market. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.
Get Sample Copy of this Report at https://www.orianresearch.com/request-sample/1608251
This report contains the major manufacturers analysis of the global Genetic Testing industry. By understanding the operations of these manufacturers (sales volume, revenue, sales price and gross margin from 2015 to 2020), the reader can understand the strategies and collaborations that the manufacturers are focusing on combat competition in the market.
Key STRATEGIC MANUFACTURERS include in this report:-
GeneDx
Invitae
Pathway Genomics
Counsyl Inc
Asper Biotech
GenePlanet
Courtagen Life Sciences
Gene By Gene
Natera Inc
Regulatory
GeneTests
United Gene
HI Gene
Berry Genomics
23andMe Inc
360Jiyin
Novogene
CapitalBio
Agen
Biomedlab
Development policies and plans are discussed as well as growth rate, manufacturing processes, economic growth and worldwide strategies are analyzed. This Genetic Testing Research Report also states import/export data, industry supply and consumption figures as well as cost structure, price, industry revenue and gross margin by regions.
This report studies the Genetic Testing market status and outlook of global and major regions, from angles of players, countries, product types and end industries, this report analyzes the top players in global Genetic Testing industry, and splits by product type and applications/end industries. This report also includes the impact of COVID-19 on the Genetic Testing industry.
Global Genetic Testing market: types and end industries analysis
The research report includes specific segments such as end industries and product types of Genetic Testing. The report provides market size (sales volume and revenue) for each type and end industry from 2015 to 2020. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Genetic Testing market: regional analysis
Geographically, this report is segmented into several key countries, with market size, growth rate, import and export of Genetic Testing in these countries from 2015 to 2020, which covering United States, Canada, Germany, France, UK, Italy, Russia, Spain, Netherlands, China, Japan, Korea, India, Australia, Indonesia, Vietnam, Turkey, Saudi Arabia, South Africa, Egypt, Brazil, Mexico, Argentina, Colombia.
Key Product Type Newborn Screening Diagnostic Testing Carrier Testing Preimplantation Genetic Diagnosis Prenatal Diagnosis Predictive and Presymptomatic Testing Pharmacogenomics Market by Application Cardiology Dermatology Hematology Hereditary Cancer Immunology Metabolic Disorders and Newborn Screening Neurology Ophthalmology Pediatric Genetics Others
Order a Copy of Global Genetic Testing Market Report @ https://www.orianresearch.com/checkout/1608251
Finally, the Report provides detailed profile and data information analysis of leading companies.
Major Points from Table of Contents-
1 Industry Overview of Genetic Testing
2 Major Manufacturers Analysis of Genetic Testing Industry
3 Global Genetic Testing Market Analysis by Regions, Manufacturers, Types and End Users
4 North America Genetic Testing Market Analysis by Countries, Types and End Users
5 Europe Genetic Testing Market Analysis by Countries, Types and End Users
6 Asia Pacific Genetic Testing Market Analysis by Countries, Types and End Users
7 Latin America Genetic Testing Market Analysis by Countries, Types and End Users
8 Middle East & Africa Genetic Testing Market Analysis by Countries, Types and End Users
9 Marketing Channel, Distributors and Traders Analysis
10 Global Genetic Testing Market Forecast by Regions, Countries, Manufacturers, Types and End Users
11 Industry Chain Analysis of Genetic Testing
12 Genetic Testing New Project Investment Feasibility Analysis
13 Genetic Testing Research Findings and Conclusion
14 Appendix
Note: We can also customize this record and provide individual chapters or a region-wise breakdown record such as North America, Europe or Asia. Also, if you have any special requirements, please let us know and we will offer you the record as you want.
About Us:
Orian Research is one of the most comprehensive collections of market intelligence records on the World Wide Web. Our records repository boasts of over 500000+ industry and country research from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the worlds most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.
Contact Us:-
Ruwin Mendez
Vice President Global Sales & Partner Relations
Orian Research Consultants
US: +1 (415) 830-3727 | UK: +44 020 8144-71-27
Direct-To-Consumer (DTC) Genetic Testing Market Growth Analysis by Size, Top Companies, Supply Demand, Trends, Demand, Overview and Forecast to 2026 -…
New Jersey, United States, The Direct-To-Consumer (DTC) Genetic Testing Market report examines the market situation and prospects and represents the size of the Direct-To-Consumer (DTC) Genetic Testing market (value and volume) and the share by company, type, application and region. The general trends and opportunities of Direct-To-Consumer (DTC) Genetic Testing are also taken into account when examining the Direct-To-Consumer (DTC) Genetic Testing industry. Direct-To-Consumer (DTC) Genetic Testing The market report focuses on the following section: Analysis of the Direct-To-Consumer (DTC) Genetic Testing industry by transfer into different segments; the main types of products that fall within the scope of the report.
This Direct-To-Consumer (DTC) Genetic Testing market report is a complete analysis of the Direct-To-Consumer (DTC) Genetic Testing market based on an in-depth primary and secondary analysis. The scope of the Direct-To-Consumer (DTC) Genetic Testing market report includes global and regional sales, product consumption in terms of volume and value. The Direct-To-Consumer (DTC) Genetic Testing market report contains an estimate of revenue, CAGR and total revenue. The knowledge gathered in world trade Direct-To-Consumer (DTC) Genetic Testing is presented in figures, tables, pie charts and graphics.
Get | Research Sample Copy By Using Corporate Mail ID @https://www.verifiedmarketresearch.com/download-sample/?rid=25584&utm_source=COD&utm_medium=007
Top 10 Companies in the Global Direct-To-Consumer (DTC) Genetic Testing Market Research Report:
Global Direct-To-Consumer (DTC) Genetic Testing Market: Drivers and Restrains
The research report included analysis of various factors that increase market growth. These are trends, restrictions and drivers that change the market positively or negatively. This section also contains information on various segments and applications that may affect the market in the future. Detailed information is based on current trends and historical milestones. This section also includes an analysis of sales volume on the Direct-To-Consumer (DTC) Genetic Testing market and for each type from 2015 to 2026. This section mentions sales volume by region from 2015 to 2026. The price analysis is included in the report Type of year 2015 to 2026, manufacturer from 2015 to 2020, region from 2015 to 2020 and total price from 2015 to 2026.
An in-depth assessment of the restrictions contained in the report describes the contrast to the drivers and leaves room for strategic planning. The factors that overshadow the growth of the market are essential as they can be understood to design different phrases to take advantage of the lucrative opportunities that the growing Direct-To-Consumer (DTC) Genetic Testing market offers. In addition, information on the opinions of market experts was used to better understand the market.
Global Direct-To-Consumer (DTC) Genetic Testing Market: Segment Analysis
The research report contains certain segments such as application and product type. Each type provides revenue information for the 2015-2026 forecast period. The application segment also provides volume revenue and revenue for the 2015-2026 forecast period. Understanding the segments identifies the importance of the various factors that support Direct-To-Consumer (DTC) Genetic Testing market growth.
Global Direct-To-Consumer (DTC) Genetic Testing Market: Regional Analysis
The research report includes a detailed study of the regions of North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. The Direct-To-Consumer (DTC) Genetic Testing report was compiled after various factors determining regional growth, such as the economic, environmental, social, technological and political status of the region concerned, were observed and examined. Analysts examined sales, sales, and manufacturer data for each region. This section analyzes sales and volume by region for the forecast period from 2015 to 2026. These analyzes help the reader understand the potential value of investments in a particular region.
Global Direct-To-Consumer (DTC) Genetic Testing Market: Competitive Landscape
This section of the report lists various major manufacturers in the market. It helps the reader understand the strategies and collaborations that players focus on to fight competition in the market. The full report provides a significant microscopic overview of the Direct-To-Consumer (DTC) Genetic Testing market. Readers can identify manufacturers footprints by knowing manufacturers global earnings, manufacturers world market prices, and manufacturers sales for the 2015-2019 forecast period.
Ask For Discounts, Click Here @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=25584&utm_source=COD&utm_medium=007
Table of Content
1 Introduction of Direct-To-Consumer (DTC) Genetic Testing Market
1.1 Overview of the Market1.2 Scope of Report1.3 Assumptions
2 Executive Summary
3 Research Methodology of Verified Market Research
3.1 Data Mining3.2 Validation3.3 Primary Interviews3.4 List of Data Sources
4 Direct-To-Consumer (DTC) Genetic Testing Market Outlook
4.1 Overview4.2 Market Dynamics4.2.1 Drivers4.2.2 Restraints4.2.3 Opportunities4.3 Porters Five Force Model4.4 Value Chain Analysis
5 Direct-To-Consumer (DTC) Genetic Testing Market, By Deployment Model
5.1 Overview
6 Direct-To-Consumer (DTC) Genetic Testing Market, By Solution
6.1 Overview
7 Direct-To-Consumer (DTC) Genetic Testing Market, By Vertical
7.1 Overview
8 Direct-To-Consumer (DTC) Genetic Testing Market, By Geography
8.1 Overview8.2 North America8.2.1 U.S.8.2.2 Canada8.2.3 Mexico8.3 Europe8.3.1 Germany8.3.2 U.K.8.3.3 France8.3.4 Rest of Europe8.4 Asia Pacific8.4.1 China8.4.2 Japan8.4.3 India8.4.4 Rest of Asia Pacific8.5 Rest of the World8.5.1 Latin America8.5.2 Middle East
9 Direct-To-Consumer (DTC) Genetic Testing Market Competitive Landscape
9.1 Overview9.2 Company Market Ranking9.3 Key Development Strategies
10 Company Profiles
10.1.1 Overview10.1.2 Financial Performance10.1.3 Product Outlook10.1.4 Key Developments
11 Appendix
11.1 Related Research
Customized Research Report Using Corporate Email Id @https://www.verifiedmarketresearch.com/product/Direct-To-Consumer-DTC-Genetic-Testing-Market/?utm_source=COD&utm_medium=007
About us:
Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyse data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.
We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defence, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080UK: +44 (203)-411-9686APAC: +91 (902)-863-5784US Toll Free: +1 (800)-7821768
Email: [emailprotected]
Read this article:
Direct-To-Consumer (DTC) Genetic Testing Market Growth Analysis by Size, Top Companies, Supply Demand, Trends, Demand, Overview and Forecast to 2026 -...
Potential Impact of COVID-19 on Predictive Genetic Testing And Consumer/Wellness Genomics Market Analyzed in a New Intelligence Study – Bulletin Line
In 2029, the Predictive Genetic Testing And Consumer/Wellness Genomics market is spectated to surpass ~US$ xx Mn/Bn with a CAGR of xx% over the forecast period. The Predictive Genetic Testing And Consumer/Wellness Genomics market clicked a value of ~US$ xx Mn/Bn in 2018. Region is expected to account for a significant market share, where the Predictive Genetic Testing And Consumer/Wellness Genomics market size is projected to inflate with a CAGR of xx% during the forecast period.
In the Predictive Genetic Testing And Consumer/Wellness Genomics market research study, 2018 is considered as the base year, and 2019-2029 is considered as the forecast period to predict the market size. Important regions emphasized in the report include region 1 (country 1, country2), region 2 (country 1, country2), and region 3 (country 1, country2).
The report on the Predictive Genetic Testing And Consumer/Wellness Genomics market provides a birds eye view of the current proceeding within the Predictive Genetic Testing And Consumer/Wellness Genomics market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Predictive Genetic Testing And Consumer/Wellness Genomics market and offers a clear assessment of the projected market fluctuations during the forecast period.
Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2675622&source=atm
Global Predictive Genetic Testing And Consumer/Wellness Genomics market report on the basis of market players
The report examines each Predictive Genetic Testing And Consumer/Wellness Genomics market player according to its market share, production footprint, and growth rate. SWOT analysis of the players (strengths, weaknesses, opportunities and threats) has been covered in this report. Further, the Predictive Genetic Testing And Consumer/Wellness Genomics market study depicts the recent launches, agreements, R&D projects, and business strategies of the market players including
Key market playersMajor competitors identified in this market include Illumina, BGI, Genesis Genetics, Myriad Genetics, 23andMe, Inc, Color Genomics Inc, Pathway Genomics, ARUP Laboratories, etc.
Based on the Region:Asia-Pacific (China, Japan, South Korea, India and ASEAN)North America (US and Canada)Europe (Germany, France, UK and Italy)Rest of World (Latin America, Middle East & Africa)
Based on the Type:Predictive TestingConsumer GenomicsWellness Genomics
Based on the Application:Breast & Ovarian CancerCardiovascular screeningDiabetic Screening & MonitoringColon CancerOther
Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2675622&source=atm
The Predictive Genetic Testing And Consumer/Wellness Genomics market report answers the following queries:
The Predictive Genetic Testing And Consumer/Wellness Genomics market report provides the below-mentioned information:
You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2675622&licType=S&source=atm
Research Methodology of Predictive Genetic Testing And Consumer/Wellness Genomics Market Report
The global Predictive Genetic Testing And Consumer/Wellness Genomics market study covers the estimation size of the market both in terms of value (Mn/Bn USD) and volume (x units). Both top-down and bottom-up approaches have been used to calculate and authenticate the market size of the Predictive Genetic Testing And Consumer/Wellness Genomics market, and predict the scenario of various sub-markets in the overall market. Primary and secondary research has been thoroughly performed to analyze the prominent players and their market share in the Predictive Genetic Testing And Consumer/Wellness Genomics market. Further, all the numbers, segmentation, and shares have been gathered using authentic primary and secondary sources.
Go here to read the rest:
Potential Impact of COVID-19 on Predictive Genetic Testing And Consumer/Wellness Genomics Market Analyzed in a New Intelligence Study - Bulletin Line
Predictive Genetic Testing Market 2020 Global Key Players, Trends, Share, Industry Size, Growth, Opportunities and Forecast to 2025 – News Distinct
Global Predictive Genetic Testing market research report provides details on key factors such as drivers, opportunities and trends expected to have a major impact on the market during the forecast period 2020-2025. It also highlights such information. Expansion and growth rates to help business owners and manufacturers plan strategies to smoothly achieve their goals in the near future. Researchers have thoroughly researched historical markets to provide insights into current market scenarios and to help companies get more information.
The given report is an excellent research study specially compiled to provide the latest insights into critical aspects of the Global Predictive Genetic Testing Market by Adroit Market Research with more market data pie charts, charts, statistics and graphs.
Get sample copy of Predictive Genetic Testing Market report @ https://www.adroitmarketresearch.com/contacts/request-sample/1276
For future market growth, global keyword market forecasts have been observed with various macroeconomic factors and changing trends according to the markets future forecasts. Other important factors covered in the report include current market size, supply and demand side inputs, and other dynamics shaping market scenarios. Report forecasting is provided in CAGR and other important criteria such as annual growth and absolute dollar opportunities are also incorporated to provide clear insights and future opportunities.
Top Leading Key Players are:
Agilent, Technologies, Inc., BGI Genomics, F.Hoffman-La Roche Ltd., Genes In Life., Invitae Corporation, Illumina, Inc., 23andMe, Myriad Genetics, Inc., Pathway Genomics and Thermo Fisher Scientific, Inc.
Read complete report with TOC at: https://www.adroitmarketresearch.com/industry-reports/predictive-genetic-testing-market
The Global Predictive Genetic Testing Market Report includes the top companies in the market, with company profile, growth aspects, opportunities and threats to market development. This report provides an industry analysis of the estimated time scale. This report covers the latest industry details related to industry reports, import and export scenarios and market share. The report also included basic opinions on the market environment, emerging and high growth sectors of the market, high growth regions, market drivers, papermaking and market opportunities. This study aims to estimate the current market size and growth potential of the global keyword market in sections like applications and representatives.
Geographically, the Predictive Genetic Testing market report is segmented as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. This analysis report similarly reduces the present, past and in future market business strategies, company extent, development, share and estimate analysis having a place with the predicted circumstances. Moreover, the possible results and the exposure to the enhancement of Predictive Genetic Testing market widely covered in this report.
The report is answerable to the following questions:1. What are the major factors driving the market growth?2. What key advancements in the near future?3. Which are the latest modernizations in the Global Predictive Genetic Testing Market Research Report 2020-2025 Market by the key players?4. What are the crucial ongoing trends observed in the market?5. What factors are restraining the market growth?
Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/1276
About Us :
Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a markets size, key trends, participants and future outlook of an industry. We intend to become our clients knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.
Contact Us :
Ryan JohnsonAccount Manager Global3131 McKinney Ave Ste 600, Dallas,TX 75204, U.S.APhone No.: USA: +1 972-362 -8199 / +91 9665341414
Continue reading here:
Predictive Genetic Testing Market 2020 Global Key Players, Trends, Share, Industry Size, Growth, Opportunities and Forecast to 2025 - News Distinct
Preimplantation Genetic Testing Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026 – Bulletin Line
The market research report published by QYResearch is a brilliant, in-dept, complete, and much-needed resource for companies, stakeholders, and investors interested in the global Preimplantation Genetic Testing market. It informs readers about key trends and opportunities in the global Preimplantation Genetic Testing market along with critical market dynamics expected to impact the global market growth. It offers a range of market analysis studies, including production and consumption, sales, industry value chain, competitive landscape, regional growth, and price. On the whole, it comes out as an intelligent resource that companies can use to gain a competitive advantage in the global Preimplantation Genetic Testing market.
Key companies operating in the global Preimplantation Genetic Testing market include Illumina, Thermo Fisher, Agilent Technologies, Perkinelmer, Coopersurgical, Abbott Laboratories, Natera, Rubicon Genomics, Oxford Gene Technology, Yikon Genomics, Scigene, Beijing Genomics Institute, Good Start Genetics, Invicta Genetics, Combimatrix, Genea Limited, Progenesis, etc.
Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :
Segmental Analysis
Both developed and emerging regions are deeply studied by the authors of the report. The regional analysis section of the report offers a comprehensive analysis of the global Preimplantation Genetic Testing market on the basis of region. Each region is exhaustively researched about so that players can use the analysis to tap into unexplored markets and plan powerful strategies to gain a foothold in lucrative markets.
Global Preimplantation Genetic Testing Market Segment By Type:
, Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis
Global Preimplantation Genetic Testing Market Segment By Application:
Maternity Centers & Fertility Clinics Hospitals, Diagnostic Labs, and Service Providers Research Laboratories & Academic Institutes
Competitive Landscape
Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Preimplantation Genetic Testing market.
Key companies operating in the global Preimplantation Genetic Testing market include Illumina, Thermo Fisher, Agilent Technologies, Perkinelmer, Coopersurgical, Abbott Laboratories, Natera, Rubicon Genomics, Oxford Gene Technology, Yikon Genomics, Scigene, Beijing Genomics Institute, Good Start Genetics, Invicta Genetics, Combimatrix, Genea Limited, Progenesis, etc.
Key questions answered in the report:
For Discount, COVID-19 Impact Analysis, Customization in the Report: https://www.qyresearch.com/customize-request/form/1781757/covid-19-impact-on-preimplantation-genetic-testing-market
TOC
1.1 Research Scope1.2 Market Segmentation1.3 Research Objectives1.4 Research Methodology1.4.1 Research Process1.4.2 Data Triangulation1.4.3 Research Approach1.4.4 Base Year1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections1.5.2 Covid-19 Impact: Commodity Prices Indices1.5.3 Covid-19 Impact: Global Major Government Policy1.6 The Covid-19 Impact on Preimplantation Genetic Testing Industry1.7 COVID-19 Impact: Preimplantation Genetic Testing Market Trends 2 Global Preimplantation Genetic Testing Quarterly Market Size Analysis2.1 Preimplantation Genetic Testing Business Impact Assessment COVID-192.1.1 Global Preimplantation Genetic Testing Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-20262.2 Global Preimplantation Genetic Testing Quarterly Market Size 2020-20212.3 COVID-19-Driven Market Dynamics and Factor Analysis2.3.1 Drivers2.3.2 Restraints2.3.3 Opportunities2.3.4 Challenges 3 Quarterly Competitive Assessment, 20203.1 By Players, Global Preimplantation Genetic Testing Quarterly Market Size, 2019 VS 20203.2 By Players, Preimplantation Genetic Testing Headquarters and Area Served3.3 Date of Key Players Enter into Preimplantation Genetic Testing Market3.4 Key Players Preimplantation Genetic Testing Product Offered3.5 Mergers & Acquisitions, Expansion Plans 4 Impact of Covid-19 on Preimplantation Genetic Testing Segments, By Type4.1 Introduction1.4.1 Preimplantation Genetic Screening1.4.2 Preimplantation Genetic Diagnosis4.2 By Type, Global Preimplantation Genetic Testing Market Size, 2019-2021 5 Impact of Covid-19 on Preimplantation Genetic Testing Segments, By Application5.1 Overview5.5.1 Maternity Centers & Fertility Clinics5.5.2 Hospitals, Diagnostic Labs, and Service Providers5.5.3 Research Laboratories & Academic Institutes5.2 By Application, Global Preimplantation Genetic Testing Market Size, 2019-20215.2.1 By Application, Global Preimplantation Genetic Testing Market Size by Application, 2019-2021 6 Geographic Analysis6.1 Introduction6.2 North America6.2.1 Macroeconomic Indicators of US6.2.2 US6.2.3 Canada6.3 Europe6.3.1 Macroeconomic Indicators of Europe6.3.2 Germany6.3.3 France6.3.4 UK6.3.5 Italy6.4 Asia-Pacific6.4.1 Macroeconomic Indicators of Asia-Pacific6.4.2 China6.4.3 Japan6.4.4 South Korea6.4.5 India6.4.6 ASEAN6.5 Rest of World6.5.1 Latin America6.5.2 Middle East and Africa 7 Company Profiles7.1 Illumina7.1.1 Illumina Business Overview7.1.2 Illumina Preimplantation Genetic Testing Quarterly Revenue, 20207.1.3 Illumina Preimplantation Genetic Testing Product Introduction7.1.4 Illumina Response to COVID-19 and Related Developments7.2 Thermo Fisher7.2.1 Thermo Fisher Business Overview7.2.2 Thermo Fisher Preimplantation Genetic Testing Quarterly Revenue, 20207.2.3 Thermo Fisher Preimplantation Genetic Testing Product Introduction7.2.4 Thermo Fisher Response to COVID-19 and Related Developments7.3 Agilent Technologies7.3.1 Agilent Technologies Business Overview7.3.2 Agilent Technologies Preimplantation Genetic Testing Quarterly Revenue, 20207.3.3 Agilent Technologies Preimplantation Genetic Testing Product Introduction7.3.4 Agilent Technologies Response to COVID-19 and Related Developments7.4 Perkinelmer7.4.1 Perkinelmer Business Overview7.4.2 Perkinelmer Preimplantation Genetic Testing Quarterly Revenue, 20207.4.3 Perkinelmer Preimplantation Genetic Testing Product Introduction7.4.4 Perkinelmer Response to COVID-19 and Related Developments7.5 Coopersurgical7.5.1 Coopersurgical Business Overview7.5.2 Coopersurgical Preimplantation Genetic Testing Quarterly Revenue, 20207.5.3 Coopersurgical Preimplantation Genetic Testing Product Introduction7.5.4 Coopersurgical Response to COVID-19 and Related Developments7.6 Abbott Laboratories7.6.1 Abbott Laboratories Business Overview7.6.2 Abbott Laboratories Preimplantation Genetic Testing Quarterly Revenue, 20207.6.3 Abbott Laboratories Preimplantation Genetic Testing Product Introduction7.6.4 Abbott Laboratories Response to COVID-19 and Related Developments7.7 Natera7.7.1 Natera Business Overview7.7.2 Natera Preimplantation Genetic Testing Quarterly Revenue, 20207.7.3 Natera Preimplantation Genetic Testing Product Introduction7.7.4 Natera Response to COVID-19 and Related Developments7.8 Rubicon Genomics7.8.1 Rubicon Genomics Business Overview7.8.2 Rubicon Genomics Preimplantation Genetic Testing Quarterly Revenue, 20207.8.3 Rubicon Genomics Preimplantation Genetic Testing Product Introduction7.8.4 Rubicon Genomics Response to COVID-19 and Related Developments7.9 Oxford Gene Technology7.9.1 Oxford Gene Technology Business Overview7.9.2 Oxford Gene Technology Preimplantation Genetic Testing Quarterly Revenue, 20207.9.3 Oxford Gene Technology Preimplantation Genetic Testing Product Introduction7.9.4 Oxford Gene Technology Response to COVID-19 and Related Developments7.10 Yikon Genomics7.10.1 Yikon Genomics Business Overview7.10.2 Yikon Genomics Preimplantation Genetic Testing Quarterly Revenue, 20207.10.3 Yikon Genomics Preimplantation Genetic Testing Product Introduction7.10.4 Yikon Genomics Response to COVID-19 and Related Developments7.11 Scigene7.11.1 Scigene Business Overview7.11.2 Scigene Preimplantation Genetic Testing Quarterly Revenue, 20207.11.3 Scigene Preimplantation Genetic Testing Product Introduction7.11.4 Scigene Response to COVID-19 and Related Developments7.12 Beijing Genomics Institute7.12.1 Beijing Genomics Institute Business Overview7.12.2 Beijing Genomics Institute Preimplantation Genetic Testing Quarterly Revenue, 20207.12.3 Beijing Genomics Institute Preimplantation Genetic Testing Product Introduction7.12.4 Beijing Genomics Institute Response to COVID-19 and Related Developments7.13 Good Start Genetics7.13.1 Good Start Genetics Business Overview7.13.2 Good Start Genetics Preimplantation Genetic Testing Quarterly Revenue, 20207.13.3 Good Start Genetics Preimplantation Genetic Testing Product Introduction7.13.4 Good Start Genetics Response to COVID-19 and Related Developments7.14 Invicta Genetics7.14.1 Invicta Genetics Business Overview7.14.2 Invicta Genetics Preimplantation Genetic Testing Quarterly Revenue, 20207.14.3 Invicta Genetics Preimplantation Genetic Testing Product Introduction7.14.4 Invicta Genetics Response to COVID-19 and Related Developments7.15 Combimatrix7.15.1 Combimatrix Business Overview7.15.2 Combimatrix Preimplantation Genetic Testing Quarterly Revenue, 20207.15.3 Combimatrix Preimplantation Genetic Testing Product Introduction7.15.4 Combimatrix Response to COVID-19 and Related Developments7.16 Genea Limited7.16.1 Genea Limited Business Overview7.16.2 Genea Limited Preimplantation Genetic Testing Quarterly Revenue, 20207.16.3 Genea Limited Preimplantation Genetic Testing Product Introduction7.16.4 Genea Limited Response to COVID-19 and Related Developments7.17 Progenesis7.17.1 Progenesis Business Overview7.17.2 Progenesis Preimplantation Genetic Testing Quarterly Revenue, 20207.17.3 Progenesis Preimplantation Genetic Testing Product Introduction7.17.4 Progenesis Response to COVID-19 and Related Developments 8 Key Findings 9 Appendix9.1 About US9.2 Disclaimer
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.
See more here:
Preimplantation Genetic Testing Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026 - Bulletin Line
Durango hatchery takes first spawn from rare cutthroat trout rescued in 416 Fire – Fort Morgan Times
DURANGO, Colo. After nearly a two-year wait, Colorado Parks and Wildlife hatchery staff and biologists in Durango have spawned a new lineage of Colorado River cutthroat trout that were rescued from a remote stream during the 416 Fire in 2018.
This marks a major milestone forCPWs on-going species conservation work in Colorado, and the result of decades of work by dedicated biologists, researchers and field staff.
Fertilized eggs of the San Juan cutthroats will hatch by mid-summer; some of the fingerlings will be placed in back-country streams in the southwest area of the state and others will be held at the Durango hatchery to start a sustainable brood stock. Now, the hatchery staff and biologists will continue the long-term effort to restore these native trout to their home waters.
Im thrilled that weve gotten a spawn from these fish, its been a long process and weve got a lot more work to do, said Jim White, aquatic biologist forCPWin Durango.
The story of these fish that hold a unique genetic marker goes back nearly 150 years and includes some serious biological detective work. Since the 1970s,CPWaquatic biologists have searched back-country streams looking for isolated populations of cutthroats Colorados native trout. In southwest Colorado in the 1980s and 1990s, biologists found cutthroat trout that were suspected to have unique characteristics in eight small streams. Back then, however, technology to analyze genetics fully was still being developed. The biologists kept their eyes on the fish and made sure non-native trout were not stocked nearby.
In 2012, researchers from the University of Colorado went to the Smithsonian National Museum of Natural History looking for preserved specimens of cutthroat trout that had been collected in Colorado. Two of the specimens they found were taken from the San Juan River near Pagosa Springs in 1874.
An analysis showed that the fish had genetic fingerprints specific to the San Juan River Basin.CPWresearchers then began a similar analysis of the cutthroats theyd found in southwest Colorado. By this time, genetic-analysis technology had advanced and in early 2018 scientists confirmed that the marker in the museum specimens matched the cutthroat trout recently found in the wild.
Biologists and hatchery staff then made a plan to start propagating the fish. The 416 Fire helped push the project along.
When the fire started north of Durango, biologists worried that ash and sediment run-off could kill the cutthroats in the remote streams. SoCPWworked with the San Juan National Forest to go into the area to capture the wild trout and bring them to a special isolation hatchery in Durango. Only 54 cutthroat were recovered from the fire area.
White and Durango Hatchery Manager Toby Mourning have been concerned because the fish did not produce any spawn last year and some of the fish died. But the turnaround this year is a major milestone for the restoration effort.
Were not getting a lot of eggs, but enough to provide some for a limited amount of stocking and some to start a captive population that will be sustainable, Mourning said.
In order to protect the fish,CPWis not providing details on stream locations. Biologists hope, however, that in a few years anglers will be able to find this unique cutthroat trout in the wild.
White explained that the work on this native is a significant conservation effort. In 2018, after the genetics of the fish were confirmed, he said: We always ask ourselves, What if we could go back to the days before mining, pioneer settlement and wide-spread non-native fish stocking to see what we had here? Careful work over the years by biologists, finding those old specimens in the museum and the genetic testing gave us the chance, essentially, to go back in time. Now we have the opportunity to bring this native trout back to southwest Colorado.
See original here:
Durango hatchery takes first spawn from rare cutthroat trout rescued in 416 Fire - Fort Morgan Times
Ask the doctor: Is there a chance I am not my sons father? – The Standard
My wife and I can both roll our tongues but our son can't. I'm worried about his paternity (Photo: Shutterstock)
I am a 36-year-old woman and have no children, but I am planning on having some in a few years. Is it true that with advancing age I increase my chances of getting a child with Downs syndrome or cerebral palsy?
ALSO READ: Ask the doctor: Is penile enlargement surgery considered plastic surgery? Does it work?
Yes, these conditions have been associated with problematic pregnancies and abnormal foetal development. After age 35, older eggs tend to have abnormal cell division where the chromosomes may fail to separate in the correct way, leading to an excess number of expected chromosomes.
For example, in Downs syndrome, the foetus has an extra chromosome resulting in what is referred to as trisomy. Cerebral palsy is associated with complications of advanced parental age, especially the mothers. These may include miscarriages, multiple births, high blood pressure, gestational diabetes, and genetic mutations that impact brain development. Studies have also suggested that an older couple is more likely to use infertility procedures that can increase the risk of multiples and other risk factors.
I discovered that my fiances sister has albinism. How likely is it that any of our future children develops the condition?
There is a 50 percent chance your fiance is a carrier for the albinism gene. If this holds true, then there is a 25 percent chance that your future children may develop this condition.
My wife can roll her tongue (the rolling tongue gene). So can I. But our son, now 4, cant. I am worried about my childs paternity but dont want to stir the marriage yet. Do you think I should be worried or is there a genetic explanation?
There should be no cause to worry. More recent studies disputed the misleading assumption that leads to the conclusion that is worrying you. There was a study on identical twins who differed in their tongue-rolling trait, suggesting that the trait was not entirely under genomic influence as identical twins have the same genetic makeup.
I hope to get a child through a sperm bank. Do you think my request for physical characteristics of the sperm donor will help towards getting desirable traits in my future child?
ALSO READ: Why its better to have children before your 40s
Yes, most physical characteristics are easily inherited from parents to their offspring. However, this could be a mixture of traits from both the donor and the recipient.
How far is the world from genetically engineering desirable traits into people and consequently having designer babies?
It is already happening on a smaller scale for certain traits, for example women or men going to sperm banks look for super straights in their donors for IVF procedures.
The world is also moving towards precision medicine, or what is commonly known as personalised medicine where everyone has their medicine tailor-made to suit their genes and condition based on their genetic fingerprint.
With technologies such as CRISPR/Cas9 gene editing, the future of designer babies is possible although ethical considerations in human cloning restrict such practices and may fail to promote advancements in these technologies.
Can I influence my childrens personalities or are they predetermined before birth?
To some extent yes, but personality is influenced by various factors. One component may come from the genes and the other from environmental interactions. For example, exposure to different life circumstances greatly influences ones personality.
ALSO READ: Ask the doctor: How do I bring back the white colour of my child's discoloured teeth?
My four-year-old twins are very different. My son has a real mean streak. Hes always been like that. His sister is kind. I have been responsible for their upbringing so far. Are character traits in the genes?
The difference could be in their genetic makeup. As we know, we inherit half of our genes from each parent and different personality traits could arise from this. In addition, the contrast in their personality could emanate from their daily interactions with the external world, such as from observations.
For More of This Stories Subscribe to the Standard Epaper to get a copy of Eve Woman in the Standard
You also have not told us if you treat the children differently whereby in most cases girls are treated kindly with lots of pampering, which is thus reflected in their behaviour. Boys who are often groomed to harden up to face the real world like men and turn out as brave warriors.
As a geneticist, do you think psychopaths are born or made?
I think it is a mixed bag of fortunes here. Psychopaths could result from nature and nurture. Several studies have pointed to the existence of genetic abnormalities in psychopaths, whereas other cases have risen purely from their upbringing. For example, we have had cases of sociopathic behaviour arising after traumatic experiences and drug addiction.Couples can undergo genetic testing to determine if they have any conditions their children can inherit (Photo: Shutterstock)
I have read a bit about genetic testing for couples, and I am considering it before we start a family. My question is, if they find something worrying (my sister died of sickle cell anaemia) can it be prevented because we know beforehand?
It may not be prevented in its entirety, but may help in early management of the outcome. It may also help in decision making whether to proceed and have children in the full knowledge that they may develop an inherited condition from parents. For your case, you could be a carrier for sickle cell disease and this prepares you to seek genetic therapy such as stem cell transplants to correct the abnormal red (sickle) cells.
I did the BRCA gene test and I have the mutated gene. What are the chances I could get ovarian or breast cancer?
A mutated BRCA gene is only an indicator of higher risk of developing either ovarian or breast cancer. It does not mean that you already have the cancer. It helps you prepare to seek and make a plan for testing and monitoring of signs of the development of these cancers so that preventative or management measures can be instituted. This may help in following a lifestyle that can reduce the chances of accelerating the development of the disease.
Is there a genetic explanation as to why children, especially firstborns, look like their fathers?
Well, it is not always the case. Physical characteristics of the offspring sometimes might be a mixture of both the mothers and fathers characteristics. There are, however, extremes where a child may look like a copy of either parent. A child is a result of the union of genes of a mother and father, and the strength of expression of these genes may differ.
There is conflicting information out there about genetically modified foods. What are the facts and fiction on this?
Genetically modified foods refer to food items whose source material production, be it plant or animal, involves intentional mixing (manipulation) of genetic material not naturally found in the pure/natural breed.
The fuss brought about by anti-GMO campaigners has been related, in my opinion, to a lack of information. The genes being included have their function known from a science point of view. However, genes may interact and the results may not be known fully. How a gene will behave in the new organism is assumed to be what is known, but it does not rule out undesired effects. However, before a gene is used in GMO, experimental tests are usually performed to understand different scenarios under which it may elicit undesired effects.
Dr Fredrick Nindo, a geneticist, is a visiting post-doctoral research fellow at the Mediterranean Infection Institute for Research in Cancer and Ageing, France.
?
Do not miss out on the latest news. Join the Eve Digital Telegram channel HERE.
Visit link:
Ask the doctor: Is there a chance I am not my sons father? - The Standard
Global Breast Cancer Predictive Genetic Testing Industry Developments & Assessment 2020-2026 : Roche,… – Azizsalon News
Breast Cancer Predictive Genetic Testing Market 2020, by Tools, Services, Business Application, Company Profiles, Trends, Demand and Investment Opportunities to 2026
A comprehensive and elaborate primary analysis on GlobalBreast Cancer Predictive Genetic TestingMarket report highlights numerous facts such as development factors, business enhancement strategies, statistical growth, financial status to help readers and clients to understand the market on a global scale. The market has uncovered rapid development in the current and past years and is going to progress with continuing development in the upcoming years. Overall, the study offers an in-depth overview of the worldwide market covering all major parameters. The study offers important statistics on the market status of producers and offers useful advice and direction for businesses and individuals interested in the industry. The research was provided for leading growth status, including developments, segmentation, landscape analysis, product types and applications. The industry report focuses on the growth opportunities, which will help the Global Breast Cancer Predictive Genetic Testing market to expand operations in the existing markets. The current Large Screen Splicing System market research report has demonstrated all the vital market growth factors and economic fluctuations mentioned owing to the immense attention gained in recent years.
Request for Sample Report @https://www.indexmarketsresearch.com/report/global-and-china-breast-cancer-predictive-genetic-testing-market/302630/#requestforsample
The report thoroughly describes and maps the Breast Cancer Predictive Genetic Testing Market with a flawless discernment on the existing situation of competition in the market. This will ultimately be helping investors as well as manufacturers if the industry, in better understanding the current and future directions, the Breast Cancer Predictive Genetic Testing Market will be headed in. This report also presents product specification, manufacturing process, and product cost structure, etc. Production is separated by regions, technology, and applications. Other important aspects that have been meticulously studied in the Breast Cancer Predictive Genetic Testing market report is Demand and supply dynamics, import and export scenario, industry processes and cost structures and major R&D initiatives. In the end, the report includes Breast Cancer Predictive Genetic Testing new project SWOT analysis, investment feasibility analysis, investment return analysis, and development trend analysis. In addition, the global Breast Cancer Predictive Genetic Testing market report delivers concise information about the federal regulations and policies that may indirectly affect market growth as well as the financial state. Further, the researchers have done the industry analysis to see the impact of numerous factors and understand the whole attractiveness of the industry. The market review helps to summaries the industrial and financial development within the industry through expert analysis. Later on, the report analyzes gross sales (volume & value), market share, market growth rate, market size on the basis of a variety of applications.
With the tables and figures, the Breast Cancer Predictive Genetic Testing market report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. The information available in the global Breast Cancer Predictive Genetic Testing market report is not only based on the facts but also on the case studies, which analysts have included to deliver appropriate information to the clients in a well-versed manner. The report also covers in-depth description, competitive scenario, wide product portfolio of prime players active in this market and business strategies adopted by competitors along with their SWOT analysis. The report also provides Porter analysis, PESTEL analysis and market attractiveness which helps to better understand the market scenario(macro and micro level). Some of these influences include annual revenue, key segments, production capacity and new products. Industry principles are also documented for market analysis. This is coupled with understanding business practices of the market, sympathetic governments presence in the industry, classifying leverage of Global Breast Cancer Predictive Genetic Testing market globally, reviewing commercial terms and conditions and analyzing market subjects and trends. The situation of the global market at the global and regional level is also described in the global Breast Cancer Predictive Genetic Testing market report through geographical segmentation.
Areas to be closely scrutinized for a clear understanding of the Breast Cancer Predictive Genetic Testing market inNorth America, Central and South America, Asia Pacific, Africa, Europe, India and others.This informative report involved some top-level manufacturers profiling. In this report, a comprehensive inquiry into the market has been completed. It consists of exams conducted on previous innovations, ongoing market conditions and future outlook.
Global Breast Cancer Predictive Genetic Testing Market Leading Players:Roche, Thermo Fisher Scientific, PerkinElmer, Quest Diagnostics, Myriad Genetics, Iverson Genetics, Cancer Genetics, OncoCyte Corporation, NeoGenomics, Invitae
Global Breast Cancer Predictive Genetic Testing Market Product Type:High Penetrant Genes, Intermediate Penetrant Genes, Low Penetrant Genes
Global Breast Cancer Predictive Genetic Testing Market Application Segment:Hospitals, Clinics, Others
Breast Cancer Predictive Genetic Testing Market Report Highlights The report provides a detailed analysis on current and future market trends to identify the investment opportunities Market forecasts till 2026, using estimated market values as the base numbers Key market trends across the business segments, Regions and Countries Key developments and strategies observed in the market Market Dynamics such as Drivers, Restraints, Opportunities and other trends In-depth company profiles of key players and upcoming prominent players Growth prospects among the emerging nations through 2026 Market opportunities and recommendations for new investments
This report provides pin-point analysis of Global Breast Cancer Predictive Genetic Testing Market:1. The report provides a forward-looking perspective on the global Breast Cancer Predictive Genetic Testing market historical data, status, and future forecast, production, revenue, consumption.2. It helps to identify rising trends, drivers, growth influencing factors in global Breast Cancer Predictive Genetic Testing market and regions.3. It provides full insights of market and in-depth analysis of market segments(by manufacturers, regions, types, and applications) to easily make business decisions.4. The report provides a 10-year forecast assessment of how the market is expected to grow in the future based on current and future market potential and advantages, opportunities and challenges.5. It helps to plan Business Strategies by understanding the rising trends shaping and enhancing Breast Cancer Predictive Genetic Testing market development.6. It helps to understand competitive developments such as expansions, acquisitions, agreements, and new product launches in the Breast Cancer Predictive Genetic Testing market.
Read Detailed Index Report @https://www.indexmarketsresearch.com/report/global-and-china-breast-cancer-predictive-genetic-testing-market/302630/
Analytical Tools:
The report offers exactly studied and analyzed data of the key industry players along with their share in the market. The analytical tools used during the research includes Porters five forces analysis, SWOT analysis, and investment feasibility and returns analysis. These vital tools are used to analyze the growth of the top vendors in the market.
Additionally, the Global Breast Cancer Predictive Genetic Testing Market report comprises the in-depth study of the market segmentation such as types and applications. However, sub-segments studying in this report are crucial for knowing the preference of the shifting market demands. Likewise, the research Global Breast Cancer Predictive Genetic Testing Market report provides the deep study of the sales medium channels, traders, dealers, distributors at global as well as local level. Moreover, the Global Breast Cancer Predictive Genetic Testing Market report
Finally, Overall data will help clients to make critical tactical business decisions as well as business planning and to know the scope of future developments. This report provides a competitive study, demand-side statistics for which we interview end-users and organize procedure surveys with the help of secondary research techniques, Breast Cancer Predictive Genetic Testing company reports, regulatory information, analytical techniques, Breast Cancer Predictive Genetic Testing production sales volume and expenditure statistics.
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
Request customize:-If you wish to find more details of the report or want a Customization Please contacts us. You can get a detailed of the entire research here.
Contact Us @sales@indexmarketsresearch.com
Read more from the original source:
Global Breast Cancer Predictive Genetic Testing Industry Developments & Assessment 2020-2026 : Roche,... - Azizsalon News
Genetic Testing Market Is Booming Across the Globe Explored in Latest Research with Top Key PlayersAbbott Laboratories, Bio-Rad Laboratories, Inc -…
The global analytical report titled Genetic Testing market has been recently published by Market Research Inc to its expansive repository which helps to make informed decisions for business clients. The study includes a comprehensive analysis of this research report further also draws attention to historical records, existing market scenario and to future predictions of market growth.
Global competitors such as Genetic Testing are also highlighted in the study in order to get a stronger and effective outlook of the competition at domestic as well as global regions. The report further also offers comprehensive information based on primary and secondary research techniques to examine the data accurately
Request A sample copy of this Genetic Testing Market report at
https://www.marketresearchinc.com/request-sample.php?id=16612
The competitive landscape has been elaborated by profiling the leading key players
Abbott Laboratories, Bio-Rad Laboratories, Inc
The main goal for the dissemination of this information is to give a descriptive analysis of how the trends could potentially affect the upcoming future of Genetic Testing Market during the forecast period. This markets competitive manufactures and the upcoming manufactures are studied with their detailed research. Revenue, production, price, market share of these players is mentioned with precise information.
The geographical segmentation includes study of global regions such as North America, Latin America, Asia-Pacific, Africa, and Europe. The report also draws attention to recent advancements in technologies and certain methodologies which further help to boost the outcome of the businesses. Furthermore, it also offers a comprehensive data of cost structure such as the cost of manpower, tools, technologies, and cost of raw material. The report is an expansive source of analytical information of different business verticals such as type, size, applications, and end-users.
Grab Your Report at an Impressive Discount
https://www.marketresearchinc.com/ask-for-discount.php?id=16612
Objectives of global Genetic TestingMarket:
The report also includes information on significant market players in order to deliver penetrative insights into the businesses with regards to successful strategies of top-notch companies. Moreover, the report offers comprehensive information of several traders by presenting accurate facts and figures of market shares.
It concludes by throwing light on the recent developments that took place in the Genetic Testing market and their influence on the future growth of this market.
Inquire more or share questions if any before the purchase on this report at
https://www.marketresearchinc.com/enquiry-before-buying.php?id=16612
About Us
Market Research Inc is farsighted in its view and covers massive ground in global research. Local or global, we keep a close check on both markets. Trends and concurrent assessments sometimes overlap and influence the other. When we say market intelligence, we mean a deep and well-informed insight into your products, market, marketing, competitors, and customers. Market research companies are leading the way in nurturing global thought leadership. We help your product/service become the best they can with our informed approach.
Contact:
Market Research Inc
Kevin
51 Yerba Buena Lane, Ground Suite,
Inner Sunset San Francisco, CA 94103, USA
Call Us: +1 (628) 225-1818
Write Us@sales@marketresearchinc.com
Here is the original post:
Genetic Testing Market Is Booming Across the Globe Explored in Latest Research with Top Key PlayersAbbott Laboratories, Bio-Rad Laboratories, Inc -...
Tale of bubonic plague in pumas revived by southern Yellowstone study – Sports and Weather Right Now
BILLINGS Before the COVID-19 pandemic, way back in the 1300s there was a pestilence known as the Black Death, also called bubonic plague.
Estimated to have killed millions during several outbreaks, the bubonic plague is caused by a bacteria known as Yersinia pestis.
Although the new coronavirus pandemic has captured headlines and attention around the world over the past two months, bubonic plague has again reared its head, this time in the Greater Yellowstone Ecosystem. Recently published research by Mark Elbrock and his associates showed 47% of the 17 cougars that were captured and had their blood drawn in the southern GYE tested positive for exposure to the plague.
This suggests that: (1) Y. pestis may be present at higher levels in the GYE than previously assumed, Elbrock wrote in the Cambridge University Press, noting that the disease was also found in four of 11 mountain lions that were necropsied. His co-authors were Winston Vickers and Howard Quigley.
The study is not the first time that exposure to Y. pestis has been found in Greater Yellowstone Ecosystem cougars. In 2006, a study co-authored by Roman Biek and Toni Ruth, along with others, tested blood from 150 cougars collected over 15 years and found relatively low exposure to the bacteria less than 20%.
Ruth also found Yellowstone cougars in 2004 and 2005 that had succumbed to bubonic plague. When captured in the winter, they were infested with fleas. The animals died in the following summer.
Its a relatively common bacteria found in wildlife, more so in southern drier areas, said Dan Stahler, leader of the Yellowstone National Park Cougar Project.
The bacteria is commonly transmitted by fleas that infest rodents, everything from mice to ground squirrels. The cougars, along with other predators like coyotes, are exposed to the virus when they catch and eat infected animals.
Felines, including bobcats and lynxsee, tend to be more susceptible to Y. pestis than canines, Stahler said. For some reason, bears appear impervious to such infections, he added.
Being aware of contagions is why Stahler and his team approach any dead animal cautiously while conducting wildlife research.
Anyone in contact with animals needs to have such diseases at the forefront of their mind, he said.
Not to be fearful, or to panic, but its important to screen for it and be careful of it, he said.
In humans, bubonic plague causes enlarged lymph nodes in the armpits, groin and neck. It can also be accompanied by fever and muscle aches, along with other flu-like symptoms. Unlike COVID-19, it cant be transmitted from an infected person to others via respiratory droplets. Bubonic plague is also easily treated with a vaccine if caught soon enough.
According to Montana Fish, Wildlife and Parks website, detailed data on the distribution of plague in wildlife in Montana is not available, although it is believed to be present throughout the state. The most recent human case of plague in Montana was in 1992 when a hunter contracted the disease from a bobcat. In 1987, a hunter was infected after skinning an infected antelope.
Across the United States, only about seven people a year are infected, according to the Centers for Disease Control and Prevention. More prevalent in the Southwest, the United States saw spikes in human infections in 2006 and 2015, according to the CDC.
Prairie dogs are another species that is often infected by bubonic plague. In trying to reintroduce black-footed ferrets across the West, outbreaks of plague have repeatedly frustrated scientists efforts. Prairie dogs are the main food source for the ferrets, which also use the rodents dens as their living quarters.
The incidence of plague seems to increase in years with cooler summers that follow wet winters, Stahler said, possibly because those conditions are more conducive to flea survival.
Yellowstone National Parks cougar study continued this winter with the capture of seven cougars. Eight of the big cats are wearing GPS collars, allowing researchers to track their movements.
Soon-to-be published research based on a graduate students work on noninvasive genetic testing, like hair samples, is being used to provide insight to the parks cougar population. Stahler said the work shows that in the Northern Range of the park, which includes the Lamar Valley, there are about 35 to 45 cougars, a robust population.
The research team also continues to collect data via remote camera traps, which also will help with population estimates of the secretive animals. At one elk calf carcass, five lions were photographed feeding over several days.
We had one cool trigger where a mule deer went racing by and was then followed by a cougar, Stahler said.
Another series showed a whitetail deer racing past a camera near Hellroaring Creek, soon followed by a wolf. The wolf later walked back past the camera.
Unfortunately, the parks winter predator study was cut short in mid-March due to the coronavirus pandemic, Stahler said. Yellowstone National Park was closed to the public on March 23.
We decided to get our people home safely, he said.
View original post here:
Tale of bubonic plague in pumas revived by southern Yellowstone study - Sports and Weather Right Now
Hereditary Testing Market 2020: Global Industry Analysis By Size, Share, Growth, Trends And Forecast To 2026 – Cole of Duty
Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Hereditary Testing market.
Trusted Business Insights presents an updated and Latest Study on Hereditary Testing Market 2019-2026. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market.The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the Hereditary Testing market during the forecast period (2019-2029).It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.
Get Sample Copy of this Report @ Hereditary Testing Market Size, Market Research and Industry Forecast Report, 2020-2026 (Includes Business Impact of COVID-19)
Industry Insights, Market Size, CAGR, High-Level Analysis: Hereditary Testing Market
The global hereditary testing market size was valued at USD 5.8 billion in 2019 and is projected to register at a CAGR of 6.3% during the forecast period. The expanding reproductive genetic health space is one of the key market drivers. Key players, such as Natera, have reported a continuous increase in test volumes in womens health genetic testing for inherited conditions. This reflects the growing acceptance of hereditary tests among the population, thereby accelerating the revenue growth.Furthermore, a consistent rise in demand for newborn screening has led to an increase in sales of DNA testing kits. For instance, in November 2019, the Division of Consolidated Laboratory Services (DCLS) of the Virginia Department of General Services screened 7,868 newborns for nearly 31 hereditary and metabolic disorders. Increasing penetration of newborn screening across the globe is further aiding in the revenue growth.
Reforms in genetic testing guidelines have led to inclusion of multigene panel testing for hereditary cancer into clinical practice. The National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines) for breast, ovarian, and colorectal cancers offers information on some of the cancer risk factors and management recommendations for single and multiple gene panels.Gradual developments in the distribution model is likely to benefit the genetic testing market. Technology providers are playing a crucial role in the market growth by improving their distribution service and increasing the efficiency of technology. Companies are using a cloud-based distribution model to make bioinformatics technology available for use by other laboratories. As of March, 2019, around 14 licensees were using Constellation software commercially for the marketing of Non-invasive Prenatal Testing (NIPT) products.Although these hereditary tests have huge advantages over conventional tests, several industry experts cited the cost and security concerns faced by consumers pertaining to the test. Moreover, lack of effective regulation of the tests is another key area that demands focused efforts. Despite these challenges, the genetic testing market is constantly expanding owing to the advantages of these innovative tests along with improved healthcare outcomes.DiseaseType Insights of Hereditary Testing Market
Product and service offerings with regard to various hereditary cancer testing continue to expand. Entry of major players, such as Quest, in this segment in the recent past, has significantly driven the hereditary testing market. Considering breast cancer genetic testing as a lucrative source of revenue, companies are focusing on business strategies to enhance their presence in this segment.One of the strategies is offering hereditary tests at a price lower than that offered by competitors. For instance, Color Genomics began selling its product for USD 259, whereas similar products offered by Myriad cost around USD 4,000. The increasing affordability of the tests is one of the key drivers of this segment. Furthermore, BRCA1 carriers have an 80% risk of developing breast cancer, which has also accelerated the developments in hereditary cancer testing market.
On the other hand, lung cancer is one of the major cancer forms that has a relatively few number of products. This is because most cases of lung cancer are not related to inherited genetic mutations. Similarly, for cervical cancer, most of the cases are caused by Human Papilloma Virus (HPV) and not genetic mutations. Lack of effective evidence over heritability of cervical cancer are driving the research activities in this market.Prenatal testing, irrespective of the associated risks, is increasingly gaining popularity. The cell-free DNA (cfDNA)-based NIPT testing is considered medically necessary by Anthem Blue Cross and Blue Shield of California. Previously, these players promoted cfDNA-based NIPT testing for trisomys 21, 18, and 13 only in high-risk pregnancies, as determined by maternal age and other factors.
Regional Insights of Hereditary Testing Market
Variations in regulatory frameworks pertaining to genetic tests across the world have significantly impacted the approval and commercialization of tests in the global market. Currently, a wide variety of genetic tests are being provided by several key companies in U.S. as well as several countries in Europe, Asia Pacific, and other regions.Europe accounted for the largest share in terms of revenue in 2019 and is likely to continue its dominance during the forecast period. This can be attributed to presence of key players providing genetic tests, high adoption of advanced treatments, and recommendations provided by government agencies to ensure the quality of hereditary testing services.In September 2019, Blueprint Genetics, a Finnish company, partnered with ARCHIMEDlife, a rare disease diagnostics company, to provide biochemical testing for rare diseases in North America. Through this partnership, both firms planned to diversify their range of genetic disease testing services to serve the customers better. Such initiatives are expected to strengthen the genetic testing scenario for hereditary disorders in North America, thereby accelerating regional revenue generation.
Market Share Insights of Hereditary Testing Market
Understanding the role of genetic mutation in disease occurrence has significantly accelerated the R&D in this market. Various retrospective studies are being carried out to understand the role of inherited mutations in disease pathology, which has led to key diagnostic developers, such as Quest Diagnostics, enter the market. Continuous authorizations and approvals of genetic tests by the government is expected to propel the organic revenue growth of operating companies.Some of the key players engaged in offering services and products in this market are Myriad Genetics, Inc.; Invitae Corporation; Illumina, Inc.; Natera, Inc.; Laboratory Corporation of America Holdings; F. Hoffmann-La Roche Ltd; Quest Diagnostics Incorporated; CooperSurgical, Inc.; Agilent Technologies, Inc.; Thermo Fisher Scientific, Inc.; Twist Bioscience; Sophia Genetics; Fulgent Genetic, Inc.; Medgenome; and CENTOGENE N.V.Furthermore, the expanding product portfolio is indicative of growing competition in the market. Each company is making focused efforts to offer products with competitive advantage. For example, cross-selling efforts by Natera helped the company witness lucrative revenue generation over the past years. The company promotes collective use of Horizon and Panorama products for women who have not undergone carrier screening tests in their first trimester.
Segmentations, Sub Segmentations, CAGR, & High-Level Analysis overview of Hereditary Testing Market Research ReportThis report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2026. For the purpose of this study, this market research report has segmented the global hereditary testing market report on the basis of disease type and region:
Disease Type Outlook (Revenue, USD Million, 2019 2030)
Hereditary Cancer Testing
Lung Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Ovarian Cancer
Prostate Cancer
Stomach/Gastric Cancer
Melanoma
Sarcoma
Uterine Cancer
Pancreatic Cancer
Others
Hereditary Non-cancer Testing
Genetic Tests
Cardiac Diseases
Rare Diseases
Other Diseases
Newborn Genetic Screening
Preimplantation Genetic Diagnosis & Screening
Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
Quick Read Table of Contents of this Report @ Hereditary Testing Market Size, Market Research and Industry Forecast Report, 2020-2026 (Includes Business Impact of COVID-19)
Trusted Business InsightsShelly ArnoldMedia & Marketing ExecutiveEmail Me For Any ClarificationsConnect on LinkedInClick to follow Trusted Business Insights LinkedIn for Market Data and Updates.US: +1 646 568 9797UK: +44 330 808 0580
Read this article:
Hereditary Testing Market 2020: Global Industry Analysis By Size, Share, Growth, Trends And Forecast To 2026 - Cole of Duty
Archdeacon: Trying to bring some good into the world – Dayton Daily News
In the big leagues hes known as a dependable reliever.
Once a star pitcher at Wright State and now a stalwart of the Houston Astros bullpen, Joe Smith is awaiting the start of his 14th Major League Baseball season.
Hes appeared in 782 games and is known for his unique delivery, a cross between sidearm and submarine style.
But its his pitch off the mound even more so than on it thats especially impactful.
Were just trying to bring some good into the world, he told me the other day when discussing one of his charitable involvements.
Smith and his wife Allie LaForce the former Miss Teen USA, an Ohio University basketball player and journalism grad and now a TNT sideline reporter known for her coverage of the NBA and college basketball March Madness are the highest profile sports couple in the Miami Valley.
They live in Bellbrook in the offseason, though their careers have them travelling around the country much of the year.
At present theyre ensconced in West Palm Beach. Smith went to Florida for spring training and was joined by Allie when the COVID-19 pandemic shut down the sports world over two months ago.
Since then they have been doing some real relief work.
With the help of the Athletes and Causes, the nonprofit organization that runs their charitable ventures, they became the driving force of the Project FRONTLINE effort that has delivered over 15,000 meals from restaurants struggling through the coronavirus closures to over-taxed doctors, nurses and hospital staff.
Were just trying to say a little thank you to those people who are making sacrifices and risking their lives for the rest of us, Smith said. At the same time were getting local restaurants involved and giving them some revenue so hopefully they can pay some employees and keep their doors open.
While the couple made a considerable monetary commitment to the venture, they also got support from other pro athletes and celebrities people like fellow Astro Josh Reddick, former big leaguer Johnny Damon, Cleveland Cavalier Kevin Love, Portland Trailblazer CJ McCollum, Cleveland Indians manager Terry Francona, celebrity chef Michael Symon and others as well many everyday people.
Theyve helped hospitals in six states and especially in and around Houston and Cleveland, where Joe had two pitching stints and where Allie, who grew up some 40 miles away in Vermilion, once worked as a sports anchor and reporter at Fox affiliate, WJW Channel 8.
Their effort caught the imagination of many and spun off in some unlikely directions.
A woman from Oberlin called and said, I dont have a restaurant, but I have 1,000 orchid plants Id like to donate. Do you think nurses would want one? Allie said.
We had them shipped to our (Athletes and Causes) headquarters in Tampa and they gave them out. And we heard stories how some nurses were in tears knowing someone cared about them.
While immersed in this project, theyve continued work with their signature HelpCureHD Foundation.
The HD is for Huntingtons Disease, the congenital disorder that causes the progressive breakdown of nerve cells in the brain and erodes mental capacity and physical capability.
There is no cure and it is usually fatal.
Joes grandmother died from HD complications in 2006 and his mother, Lee, a former elementary school teacher in her early 60s, was diagnosed with it eight years ago and for the past 2 years has lived in an Alzheimers facility near Cincinnati.
Theres a 50 percent chance that Joe and his sister Megan could inherit the disease.
When he and Allie began the foundation, the goal was to raise awareness and provide financial backing for research. In recent years the focus has switched to helping families attempt costly in vitro fertilization with genetic testing that would help them end up with HD-free embryos to be implanted.
That not only would guarantee an HD-free child, but it would stop the devastating disease from continuing its generational chain.
They had planned to do the process themselves in April, but precautions against COVID-19 prevented those medical procedures. Thats made it especially tough this month since May is Huntingtons Disease Awareness Month.
They want to help families because the costs are steep. Smith said they already have spent $47,000 in their own attempt and it can be $8,000 with every doctors visit.
Were lucky because I play baseball, but few families can afford that, he said. And a lot of its not covered by insurance. Itd be emotionally devastating to know you couldnt help your child or future generations just because of finances.
He said HD is like a combination of Alzheimers, Parkinsons and ALS:
Its the Devils Disease.
A true love story
And yet something quite angelic has been happening, Allie said:
Joes dad cant get in to see Joes mom, so he sits outside of her window every single day just so she can see him. Hes an incredible man and its a true love story.
Joes mom really isnt talking anymore, but she gets up and sees him out there and they have lunch together.
Although she said Joes mom is losing her memory and motor skills, she likes those visits. Nurses will hold a phone up to her ear and Mike, her husband of 39 years, talks to her.
She always been her sons biggest fan and over the past couple of years the family has taped his night games and played them for her the next day.
That makes these days without baseball especially tough for her.
Allie said there were times when his moms condition first began to worsen that Joe struggled with being away from her to play baseball:
He got to a point where he was questioning: Why am I playing the game? He wasnt feeling any fulfillment at the core of himself.
But then when he found that our foundation could help families get HD-free babies and change a familys future, he realized the platform and the financial capabilities he had with baseball. He started to feel a new fulfillment. That made the game worth it again.
Smith said he knows some peoples beliefs dont allow them to go along with this and thats fine But for me, this is a chance to get rid of a terrible disease.
Youre not changing eye color or height or anything else about the human being. Youre just knocking the Huntingtons gene out.
They had 24 families in their program when the pandemic put everything on hold. But recently they got word that two families one in Ohio, one in Houston have HD-free pregnancies.
That was a really rewarding moment, Smith said. Thats what were trying to do here. Were just trying to bring some good into the world.
Giving back
With their round-the-calendar careers she covering basketball and football, he playing baseball Allie said these have been the first weekends theyve had off together since they married in 2015.
While she said it was awesome for their relationship, they were even more intent on looking out for others.
I think it has to do with both of our upbringings, she said. In my hometown, my parents would run steak fries to raise money if somebody in our high school or community was in need. I can remember working at them growing up.
And when I was Miss Teen USA, I was like 16 and went all over the country raising over $100 million for different charities.
Smith continues to embrace the Wright State program which he joined as a walk-on out of Amelia High School near Cincinnati. He became the Horizon League Pitcher of the Year and in 2006 was a third-round draft pick of the New York Mets.
His career took him to Cleveland, the Los Angeles Angels, Chicago Cubs, Toronto, back to Cleveland and in December of 2017 he signed with the Astros. He suffered a ruptured Achilles in a workout the following December and pitched just 25 innings in the latter part of last season, but still had a 1.80 era.
This past December, three months shy of 36, he re-signed for $8 million over two years.
He said he was impressed with the Astros from the start:
When I walked into that clubhouse in 2018, it was unbelievable. Everybody was looking for ways to give back to the community. A lot of it had to do with the way (Hurricane) Harvey hit the city (in 2017.) They understood what people were going through and tried to help anyway they could.
Now Project FRONTLINE which sent hundreds of meals to places like the Lyndon B. Johnson Hospital and Texas Childrens Hospital is continuing that communal embrace.
And if you want to donate to either Project FRONTLINE orHelpCureHD, go toathletesandcauses.org and follow the prompts.
Back to baseball?
As restrictions are being eased across the nation, preliminary talks have begun about baseballs return this season. Last week Major League Baseball presented a 67-page proposal to the Players Association that addressed some issues.
Its going to be different, but the feeling I get from everybody (players and management) is that they all want to get back on the field and start playing, Smith said. But there are so many questions to be answered:
Whats spring training going to look like? And the regular season? Where will teams play? What will travel be like? And then theres the economic issues.
And one thing cant be overlooked here. It takes a lot more than 25 young guys running around to play baseball.
We have four coaches who are 70 years old and technically in that high-risk category. There are trainers, front office people and so many others in that group, too. We need to keep them safe.
And weve got guys in our league who are literally taking care of their families. Some have 10 people living with them. Some have their parents living with them. God forbid, you bring the virus home because one of your teammates was careless.
But on the flip side, theres also a woman in her early 60s for whom hed certainly like to be back on the field.
For all her physical struggles and cognitive issues, his mom knows exactly what hes doing, Allie said:
She knows if he had a good game or a bad one. She knows how many batters he faced. How many strikeouts he got. She loves her son so much. She knows just what hes doing.
She knows his pitch.
She knows, in so many ways, he and his wife Allie are just trying to bring some good into the world.
Thank you for reading the Dayton Daily News and for supporting local journalism. Subscribers: log in for access to your daily ePaper and premium newsletters.
Thank you for supporting in-depth local journalism with your subscription to the Dayton Daily News. Get more news when you want it with email newsletters just for subscribers. Sign up here.
See original here:
Archdeacon: Trying to bring some good into the world - Dayton Daily News
Direct-to-Consumer Genetic Testing Market Analysis Of Global Trends, Demand And Competition 2020-2028 – Cole of Duty
Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Direct-to-Consumer Genetic Testing market.
Trusted Business Insights presents an updated and Latest Study on Direct-to-Consumer Genetic Testing Market 2019-2026. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market.The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the Direct-to-Consumer Genetic Testing market during the forecast period (2019-2029).It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.
Get Sample Copy of this Report @ Direct-to-Consumer Genetic Testing Market Research Report Forecast to 2029 (Includes Business Impact of COVID-19)
Abstract, Snapshot, Market Analysis & Market Definition: Direct-to-Consumer Genetic Testing MarketIndustry / Sector Trends
Direct-to-Consumer Genetic Testing Market size was valued at USD 831.5 million in 2018 and is expected to witness 15.2% CAGR from 2019 to 2025.
U.S. DTC Genetic Testing Market Size, By Test Type, 2018 & 2025 (USD Million)
Rising prevalence of genetic diseases such as cystic fibrosis and Alzheimers globally is one of the major factors fostering direct-to-consumer genetic testing market growth. According to Global Genes, over 300 million people globally suffer from rare diseases. Recently developed DTC genetic tests allows consumer to identify probability of acquiring a specific genetic disease. Therefore, increasing adoption of DTC genetic testing for early disease detection and identification of genetic diseases will boost the industry growth over forecast timeline.
Increasing demand for personalized medications to treat genetic diseases will positively impact industry growth in forthcoming years. Individuals genome must be tested to develop personalized medicines. This increases the demand for DTC genetic kits since, it provides detailed information about individuals genetic predisposition. As detailed information regarding genetic makeup of individuals is easily available with the use of DTC genetic kits, researchers can easily design and develop personalized medicine that would help in faster patient recovery. Aforementioned factor is expected to drive the industry growth. However, high cost of DTC genetic testing kits may hamper industry growth to some extent during the forecast period.
Market Segmentation, Outlook & Regional Insights: Direct-to-Consumer Genetic Testing Market
Direct-to-Consumer Genetic Testing Market, By Test Type
Predictive testing segment will experience around 17% growth throughout the analysis period. Considerable segmental growth can be associated with rising prevalence of genetic diseases. Recently developed DTC genetic tests help to identify mutations that increase the chances of acquiring specific disease accurately. Surging awareness regarding benefits of such presymptomatic testing has reduced the mortality rates by enabling effective management of disease. Above mentioned factors have stimulated the segmental growth that is predicted to continue over the forecast timeframe.
Ancestry and relationship testing segment accounted for over 43% revenue share in 2018. Increasing awareness regarding ethnicity tests amongst the American and European population has increased the demand for DTC genetic tests. Accuracy and efficiency possessed by these tests has fostered segmental growth. Moreover, ancestry tests developed by companies such as Ancestry.com are user friendly. Availability of robust DTC ancestry tests providing meaningful clinical, genealogical and even forensic information will positively impact the segment growth.
Direct-to-Consumer Genetic Testing Market, By Technology
Targeted analysis segment was valued over USD 310 million in 2018. Targeted analysis is utilized for determining the defects in genes that are responsible for a particular disorder. Targeted genotyping can accurately measure an individuals gene pool that encodes important information regarding various diseases. Targeted analysis can be conducted at significant low cost compared to other available techniques that should augment its adoption rate over forecast timeframe.
Single nucleotide polymorphism segment will experience around 15% growth throughout the forecast period. Single nucleotide polymorphism chips specifically detect changes in single nucleotide that increases the efficiency of tests. For instance, SNP chips utilized for diagnosing hereditary cancers have detected 1300 mutations in BRCA2 genes. Various companies such as Ancestry.com and Color Genomics utilize SNP arrays that analyse gene sequences at a specific resolution and reveal detailed analysis about the defective genes that may in future cause certain disease. Increasing adoption of such advanced SNP chips in DTC testing kits will trigger the segmental growth.
Germany DTC Genetic Testing Market Size, By Technology, 2018 (USD Million)
Direct-to-Consumer Genetic Testing Market, By Region
North America direct-to-consumer genetic testing market accounted for around 39% regional share in 2018. Regional market growth can be attributed to increasing prevalence of genetic diseases. Rare genetic diseases such as thalassemia, hemophilia and anaemia require continuous and critical monitoring. According to CDC, every year more than 1,000 people are affected by thalassemia. Furthermore, American population has higher literacy rate and also, awareness regarding DTC tests is high amongst the American population that augments demand for DTC genetic tests.
Europe is estimated to experience around 15% growth over the coming years. European direct-to-consumer genetic testing market is highly regulated and for carrying out some of the genetic tests through DTC kits, customers are required to have physicians prescription. However, currently, European regulatory bodies are working on improving regulations set on DTC tests due to improved accuracy and efficiency possessed by them. Thus, improvement in regulatory scenario will positively impact regional market growth.
Latin America DTC Genetic Testing Market Size, By Country, 2025 (USD Million)
Key Players, Recent Developments & Sector Viewpoints: Direct-to-Consumer Genetic Testing Market
Few of the eminent industry players operating in direct-to-consumer genetic testing market are Ancestry, 23andMe, Color, Family Tree DNA, EasyDNA, Helix, Identigene, Full Genomes, Genesis HealthCare, Karmagenes, MyHeritage, MapMyGenome, Living DNA and Pathway Genomics. Chief industry players implement numerous initiatives such as mergers, acquisitions and new product launch to maintain their market position. Receiving approvals from regulatory bodies for new products will also foster companys revenue share. For instance, in October 2018, 23andme received first U.S. FDA approval for de novotechnology utilized in pharmacogenomic tests. This approval will enable company to launch innovative products, thereby fostering companys growth.
Direct-to-Consumer (DTC) Genetic Testing Industry Viewpoint
Direct-to-consumer genetic testing industry can be traced back to early 2000s. Earlier DTC tests were thought to be convenient as they would allow the patients to access their genetic information without involvement of physician. Although, DTC genetic testing kits had several benefits, in the initial days, they were stringently regulated by regulatory bodies. Regulatory scenario has always been stringent since the introduction of DTC genetic kits in European countries. Currently, there has been change in the regulatory scenario and European countries have started receiving approval for DTC genetic kits. Defects in the DTC kits have been reduced and people have started relying on these kits. DTC genetic testing market is sort of matured in North America due to numerous technological advancements and is still in developing phase in Asian countries. With further advancements in technology, DTC genetic tests industry will experience numerous growth opportunitie
Key Insights Covered: Exhaustive Direct-to-Consumer Genetic Testing Market1. Market size (sales, revenue and growth rate) of Direct-to-Consumer Genetic Testing industry.2. Global major manufacturers operating situation (sales, revenue, growth rate and gross margin) of Direct-to-Consumer Genetic Testing industry.3. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Direct-to-Consumer Genetic Testing industry.4. Market size (sales, revenue) forecast by regions and countries from 2019 to 2025 of Direct-to-Consumer Genetic Testing industry.
Research Methodology: Direct-to-Consumer Genetic Testing Market
Quick Read Table of Contents of this Report @ Direct-to-Consumer Genetic Testing Market Research Report Forecast to 2029 (Includes Business Impact of COVID-19)
Trusted Business InsightsShelly ArnoldMedia & Marketing ExecutiveEmail Me For Any ClarificationsConnect on LinkedInClick to follow Trusted Business Insights LinkedIn for Market Data and Updates.US: +1 646 568 9797UK: +44 330 808 0580
See the rest here:
Direct-to-Consumer Genetic Testing Market Analysis Of Global Trends, Demand And Competition 2020-2028 - Cole of Duty
Direct-To-Consumer Genetic Testing Market 2020 | Covid19 Impact Analysis | Business Outlook, Growth, Revenue, Trends and Forecasts 2027 – Cole of Duty
Direct-To-Consumer Genetic Testing Market 2020 report share informative data figures as well as important insights regarding some of the market component which is considered to be future course architects for the market. This includes factors such as market size, market share, market segmentation, significant growth drivers, market competition, different aspects impacting economic cycles in the market, demand, expected business up-downs, changing customer sentiments, key companies operating in the Direct-To-Consumer Genetic Testing Market, etc. In order to deliver a complete understanding of the global market, the report also shares some of the useful details regarding regional as well as significant domestic markets. The report presents a 360-degree overview and SWOT analysis of the competitive landscape of the industries.
Top Key players of Direct-To-Consumer Genetic Testing Market Covered In The Report:AncestryColorEasyDNAFamily Tree DNAFull GenomesGenesis HealthCareHelixIdentigeneKarmagenesLiving DNAMapMyGenome. Key Market Segmentation of Direct-To-Consumer Genetic Testing:
Market by Test Type
(Ancestry & Relationship Testing, Carrier Testing, Predictive Testing, and Nutrigenomics Testing)
Technology
(Targeted Analysis, Single Nucleotide Polymorphism (SNP) Chips, and Whole Genome Sequencing (WGS))
Direct-To-Consumer Genetic Testing Market Region Mainly Focusing:
Europe Direct-To-Consumer Genetic Testing Market (Austria, France, Finland, Switzerland, Italy, Germany, Netherlands, Poland, Russia, Spain, Sweden, Turkey, UK), Asia-Pacific and Australia Direct-To-Consumer Genetic Testing Market (China, South Korea, Thailand, India, Vietnam, Malaysia, Indonesia, and Japan), The Middle East and Africa Direct-To-Consumer Genetic Testing Market (Saudi Arabia, South Africa, Egypt, Morocco, and Nigeria), Latin America/South America Direct-To-Consumer Genetic Testing Market (Brazil and Argentina), North America Direct-To-Consumer Genetic Testing Market (Canada, Mexico, and The USA)
Factors such as industry value chain, key consumption trends, recent patterns of customer behaviors, overall spending capacity analysis, market expansion rate, etc. The report also incorporates premium quality data figures associated with financial figures of the industry including market size (in USD), expected market size growth (in percentage), sales data, revenue figures and more. This might enable readers to reach quicker decisions with data and insights at hand.
Buy Full Report Now @ https://www.qurateresearch.com/report/buy/HnM/direct-to-consumer-genetic-testing-market/QBI-CMR-HnM-738584/
(A free report data (as a form of Excel Datasheet) will also be provided upon request along with a new purchase.)
Key Highlights from Direct-To-Consumer Genetic Testing Market Study:
Income and Sales Estimation Historical Revenue and deals volume is displayed and supports information is triangulated with best down and base up ways to deal with figure finish market measure and to estimate conjecture numbers for key areas shrouded in the Direct-To-Consumer Genetic Testing report alongside arranged and very much perceived Types and end-utilize industry. Moreover, macroeconomic factor and administrative procedures are discovered explanation in Direct-To-Consumer Genetic Testing industry advancement and perceptive examination.
Assembling Analysis The Direct-To-Consumer Genetic Testing report is presently broke down concerning different types and applications. The Direct-To-Consumer Genetic Testing market gives a section featuring the assembling procedure examination approved by means of essential data gathered through Industry specialists and Key authorities of profiled organizations.
Competition Analysis Direct-To-Consumer Genetic Testing Leading players have been considered relying upon their organization profile, item portfolio, limit, item/benefit value, deals, and cost/benefit.
Demand and Supply and Effectiveness Direct-To-Consumer Genetic Testing report moreover gives support, Production, Consumption and (Export and Import).
Major Points Covered in Table of Contents:
Direct-To-Consumer Genetic Testing Market OverviewMarket Competition by ManufacturersProduction Market Share by RegionsConsumption by RegionsGlobal Direct-To-Consumer Genetic Testing Production, Revenue, Price Trend by TypeGlobal Direct-To-Consumer Genetic Testing Market Analysis by ApplicationsCompany Profiles and Key Figures in Direct-To-Consumer Genetic Testing BusinessDirect-To-Consumer Genetic Testing Manufacturing Cost AnalysisMarketing Channel, Distributors, and CustomersMarket DynamicsGlobal Direct-To-Consumer Genetic Testing Market ForecastResearch Findings and ConclusionMethodology and Data Source
In a word, the Direct-To-Consumer Genetic Testing Market report provides major statistics on the state of the Direct-To-Consumer Genetic Testing industry with a valuable source of guidance and direction for companies and individuals interested in the market. At the end, Direct-To-Consumer Genetic Testing Market Report delivers a conclusion which includes Research Findings, Market Size Evaluation, Global Market Share, Consumer Needs along with Customer Preference Change, Data Source. These factors will raise the growth of the business overall.
Contact Us:
Web:www.qurateresearch.comE-mail:[emailprotected]Ph: US +13393375221
Note: In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
COVID-19: Responding to the business impacts of Good Growth Opportunities in Global Direct-To-Consumer (DTC) Genetic Testing Market – Cole of Duty
The global Direct-To-Consumer (DTC) Genetic Testing market study encloses the projection size of the market both in terms of value (Mn/Bn US$) and volume (x units). With bottom-up and top-down approaches, the report predicts the viewpoint of various domestic vendors in the whole market and offers the market size of the Direct-To-Consumer (DTC) Genetic Testing market. The analysts of the report have performed in-depth primary and secondary research to analyze the key players and their market share. Further, different trusted sources were roped in to gather numbers, subdivisions, revenue and shares.
The research study encompasses fundamental points of the global Direct-To-Consumer (DTC) Genetic Testing market, from future prospects to the competitive scenario, extensively. The DROT and Porters Five Forces analyses provides a deep explanation of the factors affecting the growth of Direct-To-Consumer (DTC) Genetic Testing market. The Direct-To-Consumer (DTC) Genetic Testing market has been broken down into various segments, regions, end-uses and players to provide a clear picture of the present market situation to the readers. In addition, the macro- and microeconomic aspects are also included in the research.
Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2637644&source=atm
The key players covered in this studyAncestryColor GenomicsEasy DNAFamilytreeDNA (Gene By Gene)Full Genome CorporationHelix OpCo LLCIdentigeneKarmagenesLiving DNAMapmygenomeMyHeritagePathway GenomicsGenesis Healthcare23andMe
Market segment by Type, the product can be split intoCarrier TestingPredictive TestingAncestry & Relationship TestingNutrigenomics TestingOthersMarket segment by Application, split intoOnline PlatformsOver-the-Counter
Market segment by Regions/Countries, this report coversNorth AmericaEuropeChinaJapanSoutheast AsiaIndiaCentral & South America
The study objectives of this report are:To analyze global Direct-To-Consumer (DTC) Genetic Testing status, future forecast, growth opportunity, key market and key players.To present the Direct-To-Consumer (DTC) Genetic Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.To strategically profile the key players and comprehensively analyze their development plan and strategies.To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Direct-To-Consumer (DTC) Genetic Testing are as follows:History Year: 2015-2019Base Year: 2019Estimated Year: 2020Forecast Year 2020 to 2026For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Purchase reports at discounted prices!!! Offer valid till midnight!!!
Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2637644&source=atm
The Direct-To-Consumer (DTC) Genetic Testing market research covers an exhaustive analysis of the following data:
The Direct-To-Consumer (DTC) Genetic Testing market research addresses critical questions, such as
You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2637644&licType=S&source=atm
The global Direct-To-Consumer (DTC) Genetic Testing market research considers region 1 (Country 1, country 2), region 2 (Country 1, country 2) and region 3 (Country 1, country 2) as the important segments. All the recent trends, such as changing consumers demand, ecological conservation, and regulatory standards across different regions are covered in the report.
Read the rest here:
COVID-19: Responding to the business impacts of Good Growth Opportunities in Global Direct-To-Consumer (DTC) Genetic Testing Market - Cole of Duty
FRI AM News: Safety4Her aims to provide the right clothing for women in the trades; WisBusiness: The Podcast features Buckley Brinkman, WCMP -…
Safety4Her was founded by Melissa Gaglione, who saw a need and opportunity for womens clothing in the towing and trucking industry.
With the trucking, towing and manufacturing industry employing more than 5 million women and a growth rate of 22 percent annually, she decided it was time for clothing that women in those industries would want to wear.
I started my company, because I was a woman in the towing and trucking industry and found that wherever I searched, there was nothing that fit me, Gaglione said. There are no small sizes and everything was made in one size.
The existing market for safety wear is mostly for men and does not provide materials or fits that most women would find comfortable. A poor fit can cause women to face a higher risk of injury or death think baggy clothing caught in machinery which can also increase insurance risks.
In 2017 alone, Gaglione said, there were 250,000 accidents due to ill-fitting safety wear. Gaglione said she knows of some companies that sell pink safety wear, but much of it doesnt comply with the American National Standards Institute, which establishes various safety standards.
She not only made her clothing compliant with ANSI, but comfortable. All her garments are inspired by typical yoga pants, as she got her start by simply sewing on reflective gear to her yoga pants and leggings. She eventually made her own designs for women of all sizes.
Read the full story at WisBusiness.com: https://www.wisbusiness.com/?p=1452259
This weeks episode of WisBusiness: The Podcast features Buckley Brinkman, executive director and CEO of the Wisconsin Center for Manufacturing and Productivity.
WCMP collaborates with the UW Stout Manufacturing Outreach Center and the Wisconsin Manufacturing Extension Partnership to help the states manufacturers grow their businesses and become more profitable by offering services and programs.
What were doing now is helping manufacturers start to figure out how theyre going to operate, safely, responsibly and effectively as we come out of this as a state and as a nation, Buckley said.
Brinkman will also be a panelist at the 2020 Wisconsin Entrepreneurs Conference put on by the Wisconsin Technology Council on June 4. The virtual event will focus on COVID-19 economic survival, recovery and prosperity for young companies during a new normal.
He is bringing his broad perspective and connections with manufacturers across the nation, with knowledge on how cutting edge technology is implemented in manufacturing operations.
Every time we come out of a downturn, the investment in technology actually speeds up rather than slows down, said Brinkman. The companies that are going to come out of this stronger are the ones that are already making plans and looking for new opportunities for their businesses to take advantage of as the economy recovers.
Brinkman is looking forward to coming away with two or three ideas to put to use as well as two or three things that push him to think harder about what hes doing.
I just think this is an exciting time for us, I think its going to be an opportunity for all of us to show what Wisconsin can do, both in terms of our ability to open responsibility but then also to take advantage of the new opportunities that are coming along in this new economy, he said.
Listen to the podcast, sponsored by UW-Madison: https://www.wisbusiness.com/?p=1452256
The states unemployment rate soared to 14.1 percent in April, reaching a level not seen since the Great Depression.
According to a release from the state Department of Workforce Development, Wisconsins unemployment rate in April was 0.6 percent lower than the national rate of 14.7 percent.
The massive increase comes after the state was experiencing near-record low unemployment rates, with 3.1 percent in early March. More than 385,000 private-sector jobs were lost over the course of a single month, according to DWD.
The economy has taken a pretty severe hit in a very rapid manner, said DWD Chief Economist Dennis Winters in a media briefing today.
He explained the states unemployment rate approached 10 percent in the Great Recession of 2008, just under the national rate at the time. Winters also said the state didnt see current levels in a previous recession in the early 1980s.
The closest is the Great Depression when they figured the unemployment rate was around 25 percent, he said, adding that the depression of the 1930s built up over the course of months and years. This is a totally different phenomenon.
In early April, DWD had projected the states unemployment rate could reach as high as 27 percent. But based on the most recent information, Winters said the odds of that are less than 50 percent at this point.
Since the unemployment statistics are delayed by several weeks, Winters said they likely wont reflect the impact of the stay-at-home order and business restrictions being lifted until early July.
After peaking in early April, the number of initial unemployment applications in Wisconsin has since leveled off, according to the DWD website. But the daily totals are still in the thousands, and much higher than the same time last year. Between March 15 and May 16, DWD received 549,147 initial unemployment applications.
Wisconsin Manufacturers & Commerce President & CEO Kurt Bauer said a prolonged shutdown due to COVID-19 would likely be a much greater threat to the state than the virus itself.
Now is the time to return to the policies that delivered the strongest economy, lowest unemployment and largest budget reserves in Wisconsin history, he said. Wisconsin must reduce taxes, cut job-strangling red tape, and enact liability reforms that protect employers from costly and frivolous lawsuits.
See the release:
http://dwd.wisconsin.gov/news/2020/unemployment/200521-april-state.pdf
See the latest unemployment application numbers:
http://dwd.wisconsin.gov/covid19/public/ui-stats.htm
See the WMC statement:
Gov. Tony Evers says the state will dedicate $100 million from the federal CARES Act to help long-term care providers, emergency medical services, and home and community-based services.
The money is the latest chunk of the federal funding that Evers has rolled out to help various industries impacted by COVID-19. Hes now announced plans for more than $1.4 billion of the nearly $1.9 billion sent to the state.
The $100 million will be doled out in two parts. The initial phase will support immediate needs with a second release the administration says will be more targeted to additional needs of providers. In both cases, the money will support expenses directly related to COVID-19 and unexpected costs such as overtime and changes to sanitation procedures.
On a call with reporters today, Evers said the state will use how much Medicaid funding applicants receive as a basis to help divvy up the $100 million.
Evers acknowledged needs outstrip the amount of money being made available, noting he had earlier called for state money to help the facilities. But Republican lawmakers rejected his legislation that included the money.
Certainly, we will look at it, Evers said of additional state funding. But we also want to use as many resources as possible from the federal government.
Earlier today, Assembly Minority Leader Jim Steineke, R-Kaukauha, chided Evers in a letter for not providing money to long-term care facilities.
Following the announcement, Steineke said the money was better than nothing. Steineke added he heard frustrations from those in the long-term care industry that they hadnt been consulted by Evers and said providing state money isnt an option because Wisconsin is fundamentally broke.
While its a significant amount of money, in the long run its going to fall well short of what the needs are, Steineke said.
See the release:
Read Steinekes letter:
https://www.wispolitics.com/wp-content/uploads/2020/05/200521Steineke.pdf
A professor in the UW-Madison Department of Pathology and Laboratory Medicine, David OConnor, is working to develop a COVID-19 test to be used in institutions such as nursing homes or large workplaces.
OConnor was a panelist in the Wisconsin Alumni and Research Foundations third COVID-19 edition of its event series Crossroads of Ideas titled Where do we go from here?
He is anticipating federal guidelines are going to change on patients needing to be symptomatic for a test, as his lab is aiming for this test to be used for pre-symptomatic people.
He is working with Profs. Dave Beebe and Tom Friedrich to develop a colorimetric test for the virus, SARS-CoV-2 that causes the disease, COVID-19. OConnor said that one of the testing limitations right now is that it needs to take place in centralized labs with fancy equipment. But in this rapid test, a swab sample that has the viruss nucleic acid or RNA would cause the material in a tube to turn yellow; if not, pink.
We imagine that a truly rapid test would need to be deployed to nursing homes, said OConnor, noting that there are 15,000 nursing homes in the nation. You can imagine having a device that can be deployed at nursing homes, at any nursing home that has ongoing cases, it could be, having their people tested every day.
Deployment of the test would depend on a pending grant with RADx, a government program thats designed to accelerate the development and deployment of tests like this, according to OConnor.
If it gets funded, RADx will do rapid development over about a four-week period to see if it would be feasible for commercialization on a scale of millions of tests per week. If so, they aim to have it available by the end of the summer highly ambitious, especially from where we are now, he said.
Looking ahead, OConnor doesnt know how COVID-19 will behave in the winter.
A lot of people who believe they were infected last winter, were infected with something else, possibly influenza B, possibly something else, he said adding that probably only 1 percent of people in Dane County had it last winter, and they would have been classified at a higher than average risk level.
With most people having not been infected, certainly around here, its going to be an open question what happens next winter.
Also in OConnors Laboratory, investigators lead CoVen, an international collaboration developing COVID-19 animal models to test vaccines and treatments. The group has also been responsible for sequencing SARS-CoV-2 genomes from cases throughout Dane and Milwaukee Counties to understand how these viruses are moving through Wisconsin.
Gentueri Inc. contributes 55,000 COVID-19 testing kits a week to the states lab capacity and is developing new testing kits that can be used in the workplace.
Gentueris main business is working with laboratories to improve result quality and lab efficiency by advancing collection, preservation and processing of biological samples with kits. They make sexual assault kits for the Wisconsin Crime Lab, collection kits and genetic testing kits.
In mid-March, after predicting a slowdown in business, Nagy decided to expand Gentueri from four employees to 25 and pivoted to produce COVID-19 testing kits that include the nasal swabs and Viral Transport Media material that keeps the virus alive in the sample for the lab for local laboratories.
We realized that there was a shortage of the kits out there, and the fact that were a biological sample collection company we figured we have the expertise to make these, said Randy Nagy, president and CEO of Gentueri.
After a call to the state hygiene laboratory, company officials sourced the materials they would need for the kits, purchased a machine to make the kits and started producing the kits. Theyve since expanded to help other states in need: Illinois, Missouri, Indiana, Nebraska, Michigan and Kansas.
According to Nagy, what employers are looking for now is a way to test their employees to make them feel safe. With expertise in sample collection, Gentueri is developing a CollectEject Swab Kit that uses an oral sample rather than the long thin swab taken high up in the nasal cavity.
This allows an individual to easily collect a sample themselves and send it to a lab for automated processing, said Nagy.
We see a big opportunity there and that will go until there is a vaccine available, he said. This pivot has given us exposure to the genetic testing world. We can help the community and the laboratories with their immediate problem. Were not only doing it ourselves, but helping other companies in the end to provide their services as well.
DHS is conducting 376 facility-wide investigations across the state, 77 more than last week.
Long-term care facilities account for 165 of them, followed closely by 148 non-health care workplace investigations.
Long-term care facilities in the state are reporting 205 deaths due to COVID-19, making up 42 percent of total deaths in Wisconsin due to the virus.
These include nursing homes and assisted living facilities, such as community-based residential facilities and residential care apartment complexes.
Thirty-two of the investigations are in group housing facilities including correctional facilities, homeless shelters, dormitories and group homes that have identified 21 COVID-19 deaths, or 4 percent of the states total.
One hundred and twenty-nine of the states COVID-19 deaths were not linked to group housing facilities, but 132 deaths are categorized as unknown, meaning they may or may not have occurred at these facilities.
According to DHS, the unknown category exists because relevant information has only been collected since April 8.
About 18 percent of confirmed COVID-19 patients who have died in the state were over 90 years old, while another 24 percent were between 80 and 89 years old. Another 28 percent were between 70 and 79, and 16 percent were between 60 and 69.
DHS is also conducting investigations in healthcare facilities (17) and other settings (14).
A majority of the investigations are taking place in Milwaukee (69) and Brown (60) counties.
Click here to see the facilities under investigation and a breakdown by county: https://www.dhs.wisconsin.gov/covid-19/investigations.htm
All 72 counties in Wisconsin have at least one confirmed case of COVID-19 after Langlade and Taylor counties had a case overnight.
DHS reports the states COVID-19 death toll at 487 up six from the last count.
The states number of confirmed cases also rose since the previous count by 472 bringing the cumulative case count to 13,885. The positive tests results account for 5 percent of the total tests received Thursday, which is a good percentage, DHS Secretary Andrea Palm said in a briefing.
An estimated 58 percent have recovered from COVID-19, while 4 percent of patients have died. Thirty-nine percent are still in a 30-day waiting period of symptom onset or diagnosis.
Counties reporting deaths include: Milwaukee (269), Brown (29), Dane (26), Waukesha (24), Kenosha (21), Racine (20), Rock (14), Ozaukee (11), Walworth (11), Grant (10), Outagamie (5), Clark (4), Fond du Lac (4), Richland (4) and Washington (4).
Door, Richland, Sauk and Sheboygan counties report three deaths each. Jefferson and Marinette counties report two deaths each.
Adams, Bayfield, Buffalo, Burnett, Calumet, Columbia, Dodge, Iron, Jackson, Juneau, Kewaunee, Manitowoc, Marathon, Marquette, Monroe, Polk, Waupaca and Winnebago counties report one death each.
Hospitalizations in the state are up.
Of the states 13,885 confirmed cases, 16 percent have been hospitalized and 4 percent have received intensive care, according to DHS.
And the Wisconsin Hospital Associations hospital dashboard reports 398 COVID patients in hospitals statewide, up five patients from Wednesday and 46 more than a week ago. WHAs statewide patient data shows an upward trend in hospitalized patients since May 6.
DHS Secretary Andrea Palm said its safe to say the uptick in hospitalizations right now is not a result of the end of the states stay-at-home order.
This is because hospitalization lag time is longer than the testing lag time and hospitalization isnt required until a patient has been infected for a while and symptoms get bad, usually three to five weeks post infection, according to Palm.
DHS reports that 292 of the total COVID patients are in southeastern Wisconsin, which has also seen an increase in hospitalizations since May 6.
It is why we have built and worked on this surge capacity, not only at the regional level with hospital systems across the state, but also through our alternative care facility in Milwaukee and the one that we have started here in Dane that we would be able stand up quickly if we needed to, Palm said.
The state is slowly moving up to reach its capacity of 14,140 tests per day after a total of 9,365 came back Thursday, the most of any day.
If youre experiencing any symptoms of COVID-19, please get a test, Palm said.
Click here for more coronavirus resources and updates: https://www.wispolitics.com/wisconsin-coronavirus-resources/
As White House officials reportedly pressure the CDC to raise the bar for how states count COVID-19 deaths, the state Department of Health Services says its only including cases that had a positive test and for which the virus caused the patient to die.
If they tested positive for COVID-19 by a confirmatory test (for example, a PCR test that detects the virus causing COVID-19, not an antibody test), and COVID-19 is listed among the primary causes of death or among contributing causes of death, they are counted as a COVID-19-associated death, said Elizabeth Goodsitt, a spokesperson for DHS.
According to a report from the Daily Beast, members of the presidents coronavirus task force have been seeking changes to the tallying process that would likely lead to fewer deaths being reported. The report cites five unnamed CDC officials and says President Trump has used hypotheticals in which someone who has the virus dies from an unrelated cause such as falling down the stairs, and is still counted as a COVID-19 death.
Other states are using varying methods to calculate the total death toll attributed to the virus, a report from the Washington Post shows. But in Wisconsin, health officials only count it as a COVID-19 death if the disease is listed among the primary causes of death or contributing causes of death.
Goodsitt said if health officials have reason to believe a death wasnt linked to COVID-19 at all, based on the assessment of a medical provider or medical examiner, then its not counted in the states tally of virus deaths.
For example, if a patient died from an overdose or a car accident, and they were not ill, or there was evidence that their illness did not contribute to their death, they are not counted as a COVID-19-associated death, even if COVID-19 is detected, Goodsitt said in an email.
See more in Top Stories below.
#TOP STORIES#
# Medical College CEO: Wisconsin has landmark day in testing Covid-19
Originally posted here:
FRI AM News: Safety4Her aims to provide the right clothing for women in the trades; WisBusiness: The Podcast features Buckley Brinkman, WCMP -...
Family planning during the COVID-19 pandemic – WSAW
(WZAW) -- The current pandemic has upended so many aspects of everyday life, but for people considering pregnancy or already pregnant, those changes can feel even more overwhelming. With medical appointments delayed or moved to telemedicine sessions, many women may feel more uncertainty about their healthcare.
On Wednesday, genetic counselor and womens health expert Julia Wilkinson joined NewsChannel 7 at 4 to share specific steps you and your partner can do during this time while youre at home to make sure youre ready for your next appointment, either via telemedicine or in person.
The first thing Wilkinson talked about was the importance of doing your research. Gather information from both your and your partners relatives to learn about your familys health history.
Find out if theres anything in that history that you might be concerned about for your own health or for the health of your future children, she said.
Also, she said to track your menstrual cycles if youre not already doing so. Also consider taking an ovulation test or fertility test if theyve been irregular.
Wilkinson said you should also be gathering your medical records into one location, especially if youre been seeing different physicians in the last five years. Contact their offices to obtain your medical records. If not, make a list of any health events or significant medical activities. Its also a good way to be sure youre up to date on vaccines.
Lastly Wilkinson said that genetic testing is incredibly important for everyone to have. Parents may have genetic conditions that can be passed onto unborn children. Leading health organizations recommend carrier screening be offered to all women who are pregnant or planning on becoming pregnant. Tests kits are available online and can be done right at home.
That way you can do everything you need to do to prepare for that next appointment, she added.
For more information visit http://www.invitae.com
Go here to read the rest:
Family planning during the COVID-19 pandemic - WSAW
Could a patent get in between you and a Covid-19 test? Yes – The Guardian
Imagine if one company held a patent covering all methods of testing for Covid-19 antibodies. The company could charge monopoly prices for its tests and prohibit competitors including non-profit and university labs from manufacturing or administering their own. If the company made itself the countrys sole supplier, it would struggle to meet demand. The company would profit, but Americans would face waiting lists, confusion and inequitable access and the virus would keep spreading.
Would a patent holder ever exploit an outbreak of life-threatening infectious disease in this way? Yes. In 2001, the United States faced a credible threat of an anthrax outbreak, yet Bayer refused to license its patents on ciprofloxacin (Cipro), the most effective antibiotic treatment for anthrax, to competitors, even as Bayer itself struggled to supply the nations antibiotic stockpile.
It may seem outlandish to imagine one patent creating a wide-ranging monopoly on diagnostic testing, but it happened. In the 1990s and 2000s, biotech companies obtained and enforced broad patents on medical diagnostics that gave them near-total control of testing for particular conditions. One company obtained patents on methods of diagnosing people at high risk of developing breast cancer and attempted to eliminate testing at competing laboratories by sending cease-and-desist letters; another became the sole provider of genetic testing for many neurological and endocrine conditions, including muscular dystrophy and Alzheimers disease.
By 2011, the American Medical Association submitted an alarmed amicus brief to the US supreme court, lamenting that [i]t is hard to imagine how the clinical diagnostic community will continue to provide quality patient care and how physicians will continue to practice medicine in an ethical and effective manner under a patent regime that permits broad patents on the bodys natural responses to illness and medical treatment.
The supreme court listened. Between 2012 and 2014, in a trio of important cases Mayo, Myriad and Alice it confirmed that if a patent is directed to an abstract idea, natural phenomenon or natural law, it must claim something new and attributable to the inventor an inventive concept to become eligible for patent protection. A patent cant broadly claim a fundamental building block of knowledge like the human bodys antibodies to Covid-19 and tack on ubiquitous, conventional technology like using a needle to draw a blood sample containing those antibodies. These supreme court decisions helped restore patent laws traditional balance between inventors incentives and public access to technology.
The United Statess innovation economy has grown under Mayo, Myriad and Alice, with benefits to healthcare and not just diagnostic testing. For example, in 2013, Justus Decher developed a telehealth product that enables patients to consult with doctors remotely. A few years later, Decher was accused of infringing an older patent so broad it covered the basic idea of remotely consulting patients even by telephone. Fortunately, a court invalidated the patent under the supreme courts Mayo and Alice precedents. Dechers and other telehealth technologies have provided an important lifeline in the Covid-19 pandemic.
Pro-patent voices are now using the Covid-19 crisis to push the Coons-Tillis bill
Freed from overbroad patents on fundamental knowledge, we see an explosion of efforts to build and disseminate new tools to fight Covid-19, including 3-D printed and open source masks and ventilators and clinical trials on dozens of potential treatments and vaccines. While the US lags on deploying diagnostic testing, inventors are busily inventing: the FDA has authorized dozens of different Covid-19 tests. Some inventors may be motivated by the patent incentive companies can still get patents, just within limits. But much is driven by altruism, love of science and the reputation that comes from inventing something that saves millions of lives. Today, no one company monopolizes Covid-19 testing, and all benefit.
Yet some patent holders and their allies are unwisely threatening this balance. Last year, with support from the largest pharmaceutical and biotech industry trade groups, Senators Chris Coons and Thom Tillis proposed a bill that would undo Mayo, Myriad, and Alice, expanding limits on patent eligibility. Pro-patent voices are now using the Covid-19 crisis to push the Coons-Tillis bill, asserting that broad patents on now-patent-ineligible subject matter are necessary to incentivize invention of anti-Covid technologies, especially diagnostic tests. That ignores evidence that the biggest problems we face are global shortages of unpatented basic supplies like nasal swabs and a failure of federal government coordination, not a shortage of inventive activity.
Congress should reject these efforts to undo the traditional balance and expand the scope of patent eligibility. The current legal standard may not be perfect, but it is working. In the Covid-19 crisis, Congress should focus instead on policies that give healthcare workers, other essential workers, patients, and all Americans the resources they need.
Chris Morten is the supervising attorney at NYU Laws Technology Law & Policy Clinic and a fellow at NYU and Yale Law Schools. Alex Moss is a staff attorney at the Electronic Frontier Foundation, specializing in intellectual property
Follow this link:
Could a patent get in between you and a Covid-19 test? Yes - The Guardian
Direct-Access Genetic Testing Market which company is the market leader and how much its sales in 2020 and what it’s expected sales for the next 5…
Los Angeles, United StatesThe report offers an all-inclusive and accurate research study on the global Direct-Access Genetic Testing market while chiefly focusing on current and historical market scenarios. Stakeholders, market players, investors, and other market participants can significantly benefit from the thorough market analysis provided in the report. The authors of the report have compiled a detailed study on crucial market dynamics, including growth drivers, restraints, and opportunities. This study will help market participants to get a good understanding of future development of the global Direct-Access Genetic Testing market. The report also focuses on market taxonomy, regional analysis, opportunity assessment, and vendor analysis to help with comprehensive evaluation of the global Direct-Access Genetic Testing market.
Key companies operating in the global Direct-Access Genetic Testing market include : , 23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, Quest Diagnostics, Gene By Gene, DNA Diagnostics Center, Invitae, IntelliGenetics, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, Xcode, Color Genomics, Anglia DNA Services, African Ancestry, Canadian DNA Services, DNA Family Check, Alpha Biolaboratories, Test Me DNA, 23 Mofang, Genetic Health, DNA Services of America, Shuwen Health Sciences, Mapmygenome, Full Genomes Direct-Access Genetic Testing
Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :
Segment Analysis
The segmental analysis will help companies to focus on high-growth areas of the global Direct-Access Genetic Testing market. In order to broaden the overall understanding of the global Direct-Access Genetic Testing industry, the report has segregated the global Direct-Access Genetic Testing business into varied segments comprising product type, application, and end user. This examination has been carried out based on parameters like size, CAGR, share, production, and consumption. Also, region-wise assessment, wherein lucrative prospects that a region or country is likely to offer has been explored.
Global Direct-Access Genetic Testing Market Segment By Type:
, Diagnostic Screening, PGD, Relationship testing Direct-Access Genetic Testing
Global Direct-Access Genetic Testing Market Segment By Application:
, Diagnostic Screening, PGD, Relationship testing Direct-Access Genetic Testing
Competitive Landscape:
It is important for every market participant to be familiar with the competitive scenario in the global Direct-Access Genetic Testing industry. In order to fulfill the requirements, the industry analysts have evaluated the strategic activities of the competitors to help the key players strengthen their foothold in the market and increase their competitiveness.
Key companies operating in the global Direct-Access Genetic Testing market include : , 23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, Quest Diagnostics, Gene By Gene, DNA Diagnostics Center, Invitae, IntelliGenetics, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, Xcode, Color Genomics, Anglia DNA Services, African Ancestry, Canadian DNA Services, DNA Family Check, Alpha Biolaboratories, Test Me DNA, 23 Mofang, Genetic Health, DNA Services of America, Shuwen Health Sciences, Mapmygenome, Full Genomes Direct-Access Genetic Testing
Key Questions Answered
Enquire for Customization in this Report: https://www.qyresearch.com/customize-request/form/1698253/covid-19-impact-on-global-direct-access-genetic-testing-market
Table of Contents
1 Report Overview1.1 Study Scope1.2 Key Market Segments1.3 Players Covered: Ranking by Direct-Access Genetic Testing Revenue1.4 Market Analysis by Type1.4.1 Global Direct-Access Genetic Testing Market Size Growth Rate by Type: 2020 VS 20261.4.2 Diagnostic Screening1.4.3 PGD1.4.4 Relationship testing1.5 Market by Application1.5.1 Global Direct-Access Genetic Testing Market Share by Application: 2020 VS 20261.5.2 Online1.5.3 Offline1.6 Coronavirus Disease 2019 (Covid-19): Direct-Access Genetic Testing Industry Impact1.6.1 How the Covid-19 is Affecting the Direct-Access Genetic Testing Industry
1.6.1.1 Direct-Access Genetic Testing Business Impact Assessment Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products1.6.2 Market Trends and Direct-Access Genetic Testing Potential Opportunities in the COVID-19 Landscape1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Direct-Access Genetic Testing Players to Combat Covid-19 Impact1.7 Study Objectives1.8 Years Considered 2 Global Growth Trends by Regions2.1 Direct-Access Genetic Testing Market Perspective (2015-2026)2.2 Direct-Access Genetic Testing Growth Trends by Regions2.2.1 Direct-Access Genetic Testing Market Size by Regions: 2015 VS 2020 VS 20262.2.2 Direct-Access Genetic Testing Historic Market Share by Regions (2015-2020)2.2.3 Direct-Access Genetic Testing Forecasted Market Size by Regions (2021-2026)2.3 Industry Trends and Growth Strategy2.3.1 Market Top Trends2.3.2 Market Drivers2.3.3 Market Challenges2.3.4 Porters Five Forces Analysis2.3.5 Direct-Access Genetic Testing Market Growth Strategy2.3.6 Primary Interviews with Key Direct-Access Genetic Testing Players (Opinion Leaders) 3 Competition Landscape by Key Players3.1 Global Top Direct-Access Genetic Testing Players by Market Size3.1.1 Global Top Direct-Access Genetic Testing Players by Revenue (2015-2020)3.1.2 Global Direct-Access Genetic Testing Revenue Market Share by Players (2015-2020)3.1.3 Global Direct-Access Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)3.2 Global Direct-Access Genetic Testing Market Concentration Ratio3.2.1 Global Direct-Access Genetic Testing Market Concentration Ratio (CR5 and HHI)3.2.2 Global Top 10 and Top 5 Companies by Direct-Access Genetic Testing Revenue in 20193.3 Direct-Access Genetic Testing Key Players Head office and Area Served3.4 Key Players Direct-Access Genetic Testing Product Solution and Service3.5 Date of Enter into Direct-Access Genetic Testing Market3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026)4.1 Global Direct-Access Genetic Testing Historic Market Size by Type (2015-2020)4.2 Global Direct-Access Genetic Testing Forecasted Market Size by Type (2021-2026) 5 Direct-Access Genetic Testing Breakdown Data by Application (2015-2026)5.1 Global Direct-Access Genetic Testing Market Size by Application (2015-2020)5.2 Global Direct-Access Genetic Testing Forecasted Market Size by Application (2021-2026) 6 North America6.1 North America Direct-Access Genetic Testing Market Size (2015-2020)6.2 Direct-Access Genetic Testing Key Players in North America (2019-2020)6.3 North America Direct-Access Genetic Testing Market Size by Type (2015-2020)6.4 North America Direct-Access Genetic Testing Market Size by Application (2015-2020) 7 Europe7.1 Europe Direct-Access Genetic Testing Market Size (2015-2020)7.2 Direct-Access Genetic Testing Key Players in Europe (2019-2020)7.3 Europe Direct-Access Genetic Testing Market Size by Type (2015-2020)7.4 Europe Direct-Access Genetic Testing Market Size by Application (2015-2020) 8 China8.1 China Direct-Access Genetic Testing Market Size (2015-2020)8.2 Direct-Access Genetic Testing Key Players in China (2019-2020)8.3 China Direct-Access Genetic Testing Market Size by Type (2015-2020)8.4 China Direct-Access Genetic Testing Market Size by Application (2015-2020) 9 Japan9.1 Japan Direct-Access Genetic Testing Market Size (2015-2020)9.2 Direct-Access Genetic Testing Key Players in Japan (2019-2020)9.3 Japan Direct-Access Genetic Testing Market Size by Type (2015-2020)9.4 Japan Direct-Access Genetic Testing Market Size by Application (2015-2020) 10 Southeast Asia10.1 Southeast Asia Direct-Access Genetic Testing Market Size (2015-2020)10.2 Direct-Access Genetic Testing Key Players in Southeast Asia (2019-2020)10.3 Southeast Asia Direct-Access Genetic Testing Market Size by Type (2015-2020)10.4 Southeast Asia Direct-Access Genetic Testing Market Size by Application (2015-2020) 11 India11.1 India Direct-Access Genetic Testing Market Size (2015-2020)11.2 Direct-Access Genetic Testing Key Players in India (2019-2020)11.3 India Direct-Access Genetic Testing Market Size by Type (2015-2020)11.4 India Direct-Access Genetic Testing Market Size by Application (2015-2020) 12 Central & South America12.1 Central & South America Direct-Access Genetic Testing Market Size (2015-2020)12.2 Direct-Access Genetic Testing Key Players in Central & South America (2019-2020)12.3 Central & South America Direct-Access Genetic Testing Market Size by Type (2015-2020)12.4 Central & South America Direct-Access Genetic Testing Market Size by Application (2015-2020) 13 Key Players Profiles13.1 23andMe13.1.1 23andMe Company Details13.1.2 23andMe Business Overview and Its Total Revenue13.1.3 23andMe Direct-Access Genetic Testing Introduction13.1.4 23andMe Revenue in Direct-Access Genetic Testing Business (2015-2020))13.1.5 23andMe Recent Development13.2 MyHeritage13.2.1 MyHeritage Company Details13.2.2 MyHeritage Business Overview and Its Total Revenue13.2.3 MyHeritage Direct-Access Genetic Testing Introduction13.2.4 MyHeritage Revenue in Direct-Access Genetic Testing Business (2015-2020)13.2.5 MyHeritage Recent Development13.3 LabCorp13.3.1 LabCorp Company Details13.3.2 LabCorp Business Overview and Its Total Revenue13.3.3 LabCorp Direct-Access Genetic Testing Introduction13.3.4 LabCorp Revenue in Direct-Access Genetic Testing Business (2015-2020)13.3.5 LabCorp Recent Development13.4 Myriad Genetics13.4.1 Myriad Genetics Company Details13.4.2 Myriad Genetics Business Overview and Its Total Revenue13.4.3 Myriad Genetics Direct-Access Genetic Testing Introduction13.4.4 Myriad Genetics Revenue in Direct-Access Genetic Testing Business (2015-2020)13.4.5 Myriad Genetics Recent Development13.5 Ancestry.com13.5.1 Ancestry.com Company Details13.5.2 Ancestry.com Business Overview and Its Total Revenue13.5.3 Ancestry.com Direct-Access Genetic Testing Introduction13.5.4 Ancestry.com Revenue in Direct-Access Genetic Testing Business (2015-2020)13.5.5 Ancestry.com Recent Development13.6 Quest Diagnostics13.6.1 Quest Diagnostics Company Details13.6.2 Quest Diagnostics Business Overview and Its Total Revenue13.6.3 Quest Diagnostics Direct-Access Genetic Testing Introduction13.6.4 Quest Diagnostics Revenue in Direct-Access Genetic Testing Business (2015-2020)13.6.5 Quest Diagnostics Recent Development13.7 Gene By Gene13.7.1 Gene By Gene Company Details13.7.2 Gene By Gene Business Overview and Its Total Revenue13.7.3 Gene By Gene Direct-Access Genetic Testing Introduction13.7.4 Gene By Gene Revenue in Direct-Access Genetic Testing Business (2015-2020)13.7.5 Gene By Gene Recent Development13.8 DNA Diagnostics Center13.8.1 DNA Diagnostics Center Company Details13.8.2 DNA Diagnostics Center Business Overview and Its Total Revenue13.8.3 DNA Diagnostics Center Direct-Access Genetic Testing Introduction13.8.4 DNA Diagnostics Center Revenue in Direct-Access Genetic Testing Business (2015-2020)13.8.5 DNA Diagnostics Center Recent Development13.9 Invitae13.9.1 Invitae Company Details13.9.2 Invitae Business Overview and Its Total Revenue13.9.3 Invitae Direct-Access Genetic Testing Introduction13.9.4 Invitae Revenue in Direct-Access Genetic Testing Business (2015-2020)13.9.5 Invitae Recent Development13.10 IntelliGenetics13.10.1 IntelliGenetics Company Details13.10.2 IntelliGenetics Business Overview and Its Total Revenue13.10.3 IntelliGenetics Direct-Access Genetic Testing Introduction13.10.4 IntelliGenetics Revenue in Direct-Access Genetic Testing Business (2015-2020)13.10.5 IntelliGenetics Recent Development13.11 Ambry Genetics10.11.1 Ambry Genetics Company Details10.11.2 Ambry Genetics Business Overview and Its Total Revenue10.11.3 Ambry Genetics Direct-Access Genetic Testing Introduction10.11.4 Ambry Genetics Revenue in Direct-Access Genetic Testing Business (2015-2020)10.11.5 Ambry Genetics Recent Development13.12 Living DNA10.12.1 Living DNA Company Details10.12.2 Living DNA Business Overview and Its Total Revenue10.12.3 Living DNA Direct-Access Genetic Testing Introduction10.12.4 Living DNA Revenue in Direct-Access Genetic Testing Business (2015-2020)10.12.5 Living DNA Recent Development13.13 EasyDNA10.13.1 EasyDNA Company Details10.13.2 EasyDNA Business Overview and Its Total Revenue10.13.3 EasyDNA Direct-Access Genetic Testing Introduction10.13.4 EasyDNA Revenue in Direct-Access Genetic Testing Business (2015-2020)10.13.5 EasyDNA Recent Development13.14 Pathway Genomics10.14.1 Pathway Genomics Company Details10.14.2 Pathway Genomics Business Overview and Its Total Revenue10.14.3 Pathway Genomics Direct-Access Genetic Testing Introduction10.14.4 Pathway Genomics Revenue in Direct-Access Genetic Testing Business (2015-2020)10.14.5 Pathway Genomics Recent Development13.15 Centrillion Technology10.15.1 Centrillion Technology Company Details10.15.2 Centrillion Technology Business Overview and Its Total Revenue10.15.3 Centrillion Technology Direct-Access Genetic Testing Introduction10.15.4 Centrillion Technology Revenue in Direct-Access Genetic Testing Business (2015-2020)10.15.5 Centrillion Technology Recent Development13.16 Xcode10.16.1 Xcode Company Details10.16.2 Xcode Business Overview and Its Total Revenue10.16.3 Xcode Direct-Access Genetic Testing Introduction10.16.4 Xcode Revenue in Direct-Access Genetic Testing Business (2015-2020)10.16.5 Xcode Recent Development13.17 Color Genomics10.17.1 Color Genomics Company Details10.17.2 Color Genomics Business Overview and Its Total Revenue10.17.3 Color Genomics Direct-Access Genetic Testing Introduction10.17.4 Color Genomics Revenue in Direct-Access Genetic Testing Business (2015-2020)10.17.5 Color Genomics Recent Development13.18 Anglia DNA Services10.18.1 Anglia DNA Services Company Details10.18.2 Anglia DNA Services Business Overview and Its Total Revenue10.18.3 Anglia DNA Services Direct-Access Genetic Testing Introduction10.18.4 Anglia DNA Services Revenue in Direct-Access Genetic Testing Business (2015-2020)10.18.5 Anglia DNA Services Recent Development13.19 African Ancestry10.19.1 African Ancestry Company Details10.19.2 African Ancestry Business Overview and Its Total Revenue10.19.3 African Ancestry Direct-Access Genetic Testing Introduction10.19.4 African Ancestry Revenue in Direct-Access Genetic Testing Business (2015-2020)10.19.5 African Ancestry Recent Development13.20 Canadian DNA Services10.20.1 Canadian DNA Services Company Details10.20.2 Canadian DNA Services Business Overview and Its Total Revenue10.20.3 Canadian DNA Services Direct-Access Genetic Testing Introduction10.20.4 Canadian DNA Services Revenue in Direct-Access Genetic Testing Business (2015-2020)10.20.5 Canadian DNA Services Recent Development13.21 DNA Family Check10.21.1 DNA Family Check Company Details10.21.2 DNA Family Check Business Overview and Its Total Revenue10.21.3 DNA Family Check Direct-Access Genetic Testing Introduction10.21.4 DNA Family Check Revenue in Direct-Access Genetic Testing Business (2015-2020)10.21.5 DNA Family Check Recent Development13.22 Alpha Biolaboratories10.22.1 Alpha Biolaboratories Company Details10.22.2 Alpha Biolaboratories Business Overview and Its Total Revenue10.22.3 Alpha Biolaboratories Direct-Access Genetic Testing Introduction10.22.4 Alpha Biolaboratories Revenue in Direct-Access Genetic Testing Business (2015-2020)10.22.5 Alpha Biolaboratories Recent Development13.23 Test Me DNA10.23.1 Test Me DNA Company Details10.23.2 Test Me DNA Business Overview and Its Total Revenue10.23.3 Test Me DNA Direct-Access Genetic Testing Introduction10.23.4 Test Me DNA Revenue in Direct-Access Genetic Testing Business (2015-2020)10.23.5 Test Me DNA Recent Development13.24 23 Mofang10.24.1 23 Mofang Company Details10.24.2 23 Mofang Business Overview and Its Total Revenue10.24.3 23 Mofang Direct-Access Genetic Testing Introduction10.24.4 23 Mofang Revenue in Direct-Access Genetic Testing Business (2015-2020)10.24.5 23 Mofang Recent Development13.25 Genetic Health10.25.1 Genetic Health Company Details10.25.2 Genetic Health Business Overview and Its Total Revenue10.25.3 Genetic Health Direct-Access Genetic Testing Introduction10.25.4 Genetic Health Revenue in Direct-Access Genetic Testing Business (2015-2020)10.25.5 Genetic Health Recent Development13.26 DNA Services of America10.26.1 DNA Services of America Company Details10.26.2 DNA Services of America Business Overview and Its Total Revenue10.26.3 DNA Services of America Direct-Access Genetic Testing Introduction10.26.4 DNA Services of America Revenue in Direct-Access Genetic Testing Business (2015-2020)10.26.5 DNA Services of America Recent Development13.27 Shuwen Health Sciences10.27.1 Shuwen Health Sciences Company Details10.27.2 Shuwen Health Sciences Business Overview and Its Total Revenue10.27.3 Shuwen Health Sciences Direct-Access Genetic Testing Introduction10.27.4 Shuwen Health Sciences Revenue in Direct-Access Genetic Testing Business (2015-2020)10.27.5 Shuwen Health Sciences Recent Development13.28 Mapmygenome10.28.1 Mapmygenome Company Details10.28.2 Mapmygenome Business Overview and Its Total Revenue10.28.3 Mapmygenome Direct-Access Genetic Testing Introduction10.28.4 Mapmygenome Revenue in Direct-Access Genetic Testing Business (2015-2020)10.28.5 Mapmygenome Recent Development13.29 Full Genomes10.29.1 Full Genomes Company Details10.29.2 Full Genomes Business Overview and Its Total Revenue10.29.3 Full Genomes Direct-Access Genetic Testing Introduction10.29.4 Full Genomes Revenue in Direct-Access Genetic Testing Business (2015-2020)10.29.5 Full Genomes Recent Development 14 Analysts Viewpoints/Conclusions 15 Appendix15.1 Research Methodology15.1.1 Methodology/Research Approach15.1.2 Data Source15.2 Disclaimer15.3 Author Details
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become a brand of quality assurance in the consulting industry.